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CHAPTER I 
I NTROOOCTION 
Glucocorticoids affect carbohydrate metabolism in three major 
areas: enhance the deposition of liver glycogen to a greater extent 
than muscle glycogen, disturb carbohydrate utilization, and pro -
mote gluconeogenesis. These effects have been well known _for some 
twenty years; however, the literature reveals that there is yet, 
after two decades of research, no definite conclusion as to which 
of the above is the primary effect and what is the consequence of 
this initial event. Much of the more recent work in this area has 
been an attempt to elucidate the mechanism by which these steroids 
influence the metabolism of carbohydrate. 
Conflicting reports have been published concerning the res-
piratory stimulating capacity of these glucocorticoids, both 
naturally occurring and synthetic. This conflict is not surpris -
ing in view of the various tissues used and differences in the 
duration of the treatment. At the present time there are only 
postulates to explain this resp'iratory stimulating property of 
the glucocorticoids. The research reported herein was carried out 
to either confirm or deny previous reports of increased respiration 
following glucocorticoid administration and to study further any 
effects which these hormones may have upon hepatic glycolysis in 
rat liver homogenates. 
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Prednisolone, a synthetic adrenal c.ortical hormone, was selected 
for use in this study because of its high glucocorticoid potency. 
Following the determination of the optimum dose and optimum time 
interval for prednisolone to stimulate respiration, an experiment was 
designed to study the liver reducing glycolytic intermediates and glyco-
gen metabolism and r,espiration of intact., of adrenalectomizeds and of 
fasted-adrenalectomized rats. 
CHAPTER II 
REVIEW OF LITERATURE 
Deposition of Glycogen 
In 1932, Britton and Silverte (14) demonstrated that adrenal 
cortical extracts caused an elevation of blood glucose and liver 
glycogen within one hour following injections into normal cats, 
rabbits, and rats. Their results showed that the storage of glyco-
gen was enhanced three to five times above that found in controls. 
A study of the interrelation of the pituitary and the adrenal in 
the control of carbohydrate levels in the rat showed that the fast-
ing muscle glycogen of adrenalectomized rats is maintained within 
normal limits by adrenal cortical extract and salt therapy (8) . 
This same treatment had no effect on hypophysectomized rats although 
crude anterior pituitary extracts did maintain the fasting muscle 
glycogen (14, 71). Since then it has been shown that ACTH will 
restore to normal the decreased ability of hypophysectomized ani-
mals to synthesize glycogen from glucose (1, 21). Long and Lukens 
(58) noted that hypophysectomy or adrenalectomy alleviates diabetes 
resulting from pancreatomy in the cat as evidenced by a decrease in 
the excretion of glucose, nitrogen, and acetone bodies. In compar-
ing the effects of growth hormone and ACTH on urinary glucose and 
nitrogen excretion by alloxan diabetic rats, Bennett (9) noted that 
only the adrenocorticotrophic hormone produced a typical exacerbation 
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of the diabetes with the enhancement of both glycosuria and nitrogen 
excretion. In another of the earlier studies on the relationship be-
tween the adrenal cortex and carbohydrate metabolism, Long and cowork-
ers (57) demonstrated that the administration of cortica l extracts 
or crystalline adrenal steroids to fasted normal or adrenalectomized 
rats and mice resulted in a large increase in liver glycogen and a 
slight hyperglycemia. Furthermore, the cortical extract decreased 
the proportion of glucose oxidized while there was an increase in 
the proportion deposited as liver glycogen. 
Using c 14o2 and glucose-6-c14 as labelled substrates, Ashmore 
et ~l. (6) studied the acute effects of hydrocortisone administra-
tion on liver glycogen deposition in fasted rats. Their results 
indicated that hydrocortisone increased the incorporation of the 
label from radioactive bicarbonate into liver glycogen but not into 
either blood glucose or liver dicarboxylic acids and increased the 
glycogen deposition from the labelled glucose. Recently Glenn 
et al. (27) demonstrated that in fasted-adrenalectomized rats, 
hydrocortisone influences the disposition of glucose or its immediate 
metabolites and that insofar as liver glycogen synthesis is con-
cerned, fat, protein, and amino acids are relatively unimportant 
in this regard. These workers concluded that it is the availability 
of glucose , not the increased synthesis that determines the qu antita= 
tive aspect of the glycogenic response to hydrocortisone . 
Kostyo (42) reported that neither cortisol nor cortisone in-
creased glycogen deposition in the uterus. It has been claimed ( 50 ) 
that hypophyseal hormones and insulin are both required in addition 
to the corticosteroids for deposition of liver glycogen . The re-
sults of Leonard (53) indicate that not all skeletal muscles respond 
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alike in deposition of glycogen under the influence of hormones. Cor-
tisone acetate was injected into normal, gonadectomized, and hypophy-
sectomized rats of both sexes to determine the effect on the glycogen 
levels in the following skeletal muscles; rectus femoris, abdominal 
muscles, cremaster of the mal~ and the diaphragm of the female. The 
hormone caused an increase in the glycogen content of the rectus fe-
moris but not in the cremaster. A sexual difference was noted in that 
cortisone treatment caused more glycogen deposition in the muscles of 
the female than in the male. 
It has been reported that hydrocortisone (compound F) (20) and 
cortisone (67) reduce carbohydrate tolerance in man, while fructose 
and galactoi:etolerances were found to be unchanged (67). Deposition 
of liver glycogen and decreased glucose tolerance can result from 
either decreased utilization or increased production of glucose or 
both. 
Cortisone has been shown to inhibit oxidation of alpha-keto-
glutarate by liver mitochondria even though the P/0 ratios remained 
within normal ranges (16). This suggests the possibility of a par-
-tial block at some point in the Krebs cycle. This cortisone-
induced block could explain the increased liver glycogen content 
in cortisone-treated animals. 
Winteritz and associates (84) demonstrated that a subcutaneous 
injection of epinephrine into fasted-adrenalectomized rats promotes 
a decrease in muscle glycogen almost two times as great as intact 
animals, with practically no accumulation of liver glycogen. In-
jections of adrenalcortical hormones restored the normal pattern of 
response. 
Kerpolla (39) demonstrated that cortisone retards skeletal 
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muscle phosphorylase activity in the rabbit, while Leonard (54) noted 
that cortisone had no effect on the phosphorylase activity of muscle 
and that both cortisone and cortisol increased muscle glycogen levels 
(59). A striking correlation between increased phosphorylase activi-
ty and liver glycogen deposition in fasted adrenalectomized rats 
receiving cortisone acetate was reported by Hess and coworkers (33). 
Adrenalectomy caused a significant decrease in the phosphorylase 
activity of fasted (33) and adrenalectomized rats (81). 
Carbohydrate Utilization 
Lacroix and Leusen (47) found that the utilization of glucose 
and pyruvate by surviving heart slices was markedly impaired by 
cortisone acetate administration to rats for 14 to 16 days before 
sacrifice. Alpha-ketoglutarate and succinate stimulated oxygen 
consumption by the heart slices to the same extent in the treated 
animals as in the control, suggesting a block in Krebs cycle some-
where between py:ruvate and alpha-ketoglutarate. 
It has been shown by Overell and associates (66 ) that near 
physiological doses of hydrocortisone, cortisone, predni so l one, 
and cortisone acetate inhibit glucose uptake in mouse skin . Herman 
and Ramey (31) noted that hydrocortisone inhibits glucose uptake 
by rat diaphragms incubated in Krebs-Ringer phosphate medium wh en 
added in vitro at a concentration of 40 ug./ml. or when injected 
into rats at a dose levels of 0.3 mg. daily for 7 days or 2 mg. 
six hours before sacrifice. Although a decrease in the production 
of lactic acid from pyruvate in the diaphragms of adrenalectomized 
rats was demonstrated by Villee P.t al. (76), the rate of conversion 
of pyruvate to CO2 by this muscle remained normal. Cohn et al . (18) 
reported a decreased utilization of glucose in extra-hepatic tissues 
of adrenalectomized dogs and an increased utilization in animals 
receiving cortisone. Cortisol restored to normal the decreased 
production of glucose by the liver in hypophysectomized dogs (2). 
Glucose-6-phosphatase is the enzyme responsible for the last 
step in the conversion of glycogen to blood glucose,and glucose 
production by the liver seems to be correlated with this enzyme-
activity (68). In the absence of glucose-6-phosphatase, an in-
crease in liver glycogen would be expected. Cori and Cori (22) 
were the first to suggest that high glycogen levels in the liver 
may be due to the low activity of this enzyme. Nemeth (65) noted 
a striking correlation between glucose-6-phosphatase and glycogen 
content in the fetal guinea pig liver: glycogen in the fetal liver 
rose steadily during the last few days of gestation during which 
time glucose-6-phosphatase activity was virtually absent; at par-
turition the phosphatase activity was increased rapidly and liver 
glycogen levels fell off correspondingly. 
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Increased glucose-6-phosphatase activity has been reported in 
the livers of diabetic (4, 5, 25, 49, 55), of fasted (5, 25, 26), 
and of steroid treated (5, 45 9 49, 55, 77, 78) rats. This in part 
explains the blood glucose elevation found in glucocorticoid treated 
animals and in metabolic conditions associated with an increased 
endogenous production of glucose. Glucose-6-phosphatase activity 
was also increased in the kidney of fasted or diabetic intact 
animals (25). Insulin reduces this increase in activity in steroid 
treated (55), diabetic (4, 55), and adrenalectomized-hydrocorti-
sone treated (55) animals. 
The administration of 17-0H corticosterone to adrenalecto-
mized-diabetic rats stimulated an increased gluconeogenesis whi~h 
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preceded by several hours the increase in liver glucose-6-phosphatase 
activity; the adrenal cortical hormones appear to act within 2 
hours after injection to alter pyruvate metabolism in liver slices 
from adrenalectomized-diabetic rats (5). Weber et al. (77) demon-
strated that the percentage intracellular distribution of glucose-
b-phosphatase in liver homogenates was not affected by fasting nor 
by cortisone treatment. 
Kvam and Parks (45) in an attempt to elucidate the mechanism 
by which hydrocortisone induced the changes in glucose-6-phosphatase 
and fructose diposphatase activity demonstrated that the increase 
was inhibited by the methionine antagonist, ethionine. The inhi-
bition was reversed by the addition of methionine, suggesting that 
the increase in enzyme activity involves the synthesis of new 
enzyme protein rather than an activation mechanism since methionine 
had to be available before an increase in enzyme activity could 
occur. 
One of the early suggestions as to the mechanism by which the 
adrenal cortical steroids inhibit carbohydrate utilization was 
made by Colowick, Cori.and Slein (19). These workers demonstrated 
that the hexokinase activity of muscle extracts from al l oxan-
diabetic r ats could be inhibited by the addition of adrenal corti -
cal extracts; whereas, hexokinase activity of extracts from normal 
muscle remained unchanged by treatment. An inhibition in hexo-
kinase activity in the normal muscle was produced by the addition 
of a protein fraction from the anterior pituitary. It was con-
cluded that the inhibitory effect of adrenal cortex extract depends 
on the presence of a factor of pituitary origin, probably somato-
trophin. Bacila and Barron (7) suggested from their studies that 
the adrenal hormones inhibit glycolysis by combining with the 
-SH groups of hexokinase. Kerpolla (40) proposed an impairment of 
the hexokinase function due to the uncoupling of oxidative 
phosphorylation by cortisone, resulting in depressed production 
of ATP. An overnight fast of rats led to decreased liver ATP 
content with corresponding increases in the ADP and AMP contents 
(10). 
Belcher and White (11) determined the factors which limit 
the rates of anaerobic glycolysis of glucose, glucose-6-phosphate, 
fructose-6-phosphate,and fructose 1, 6-diphosphate in fortified 
cell-free homogenates of rat lymphosarcoma. These factors in-
cluded a low level of tissue hexokinase, regulatior1 of the activi-
ty of the hexokinase reaction by a limited glycolytic regeneration 
of ATP, and exceedingly active ATPase. This study demonstrates 
that cortisol inhibits anaerobic glycolysis of glucose at the 
hexokinase and ATPase for the supply of ATP. 
The adrenal cortical steroids have been shown to affect the 
activity of other enzymes in the glycolytic pathway and in the 
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Krebs cycle. Adrenalectomy reduced the activity of phosphoglu-
comutase and phosphoglucose isomerase (81). Cortisone, hydro= 
cortisone 3 and corticosterone are all capable of maintaining an 
elevated level of phosphoglucose isomerase~ whereas the two former 
hormones exert a similar effect upon phosphoglucomutase (Sl)o Lee 
(52) observed that prednisolone inhibited pyruvic oxidase activity. 
Cortisone and ACTH decreased the rate of phosphoglyceromutase and 
enolase activity in both sexes of rats, thus depressing the forma-
tion of phosphoenol pyruvate from 3-phosphoglycerate (44). Kerppola 
and Pitkanen (41) found that the activities of glucose-6-phosphate 
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isomerase, aldolase, glycerophosphate kinase, and lactic dehydrogenase 
were unaltered in 1iver mitochondrial supernatants from rats pre-
v1ous1y treated with cortisone. 
Grossfeld (30), using mouse fibroblast tissue cultures, noted 
that the addition to 150 ug. of hydrocortisone to the cell suspension 
in the Warburg apparatus inhibited respiration which was coupled with 
a significant increase of aerobic glycolysis. It was suggested that 
the increase of glycolysis may be due to inhibition of respiration 
in accordance the "Pasteur effect". Pasteur, in 1861, noted this 
effect in his studies on alcoholic fermentation; under anaerobic 
conditions much more sugar was taken up, per quantity of yeast present, 
than was consumed in the presence of air. Johnson (38) proposed that 
since in the absence of either inorganic phosphate or a phosphate 
acceptor neither glycolysis nor oxidation can proceed. The Pasteur 
effect could be due to cessation or reversal of glycolysis which 
occurs when inorganic phosphate and phosphate acceptors concentrations 
become low because of the phosphorylative oxidations which occur in 
the presence of oxygen. The stimulation of both respiration and 
aerobic glycolysis was demonstrated in tissue cultures to which 1. 50 
~9· of hydrocortisone was added at 96, 24, and O hours before the 
manometric experiments (30). 
Chronic (7-17 days) administration of glucocorticoids has 
been shown to depress oxygen uptake of myocardial tissue (38, 46), 
kidney slices (38), and liver homogenates (28, 29). There are 
conflicting reports concerning the effect on oxygen consumption 
by the diaphragm; Kowalswski and Beksi (38) noted a significant 
decrease, while Lacroix and Leusen (46) demonstrated a pronounced 
increase in oxygen uptake by diaphragm muscle tissue. In both 
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instances male rats weregiven the steroid chronically. No signifi-
cant change in oxygen uptake was demonstrated in the female rat 
diaphragm (46). Goetsch (28, 29) observed an increased oxygen uptake 
by liver homogenates following a single injection of prednisolone. 
Cohen (17) recorded that glucose inhibited respiration in the 
postnatal rabbits retina prior to the formation of the sensory 
elements by as much as 40 percent. 
An inhibition of the oxygen uptake by liver mitochIDndria from 
rats treated chronically with cortisone has been demonstrated (41); 
the decrease was noted at the cytochrome c oxidase portion of the 
cytochrome chain. 
Respiratory quotients and c14o2 production from 2-C14 pyruvate 
were studied by Winternitz and Kline (83) in normal and adrenalec-
tomized rats following the subcutaneous injection of epinephrine as 
a carbohydrate mobilizing agent. These results indicated an eleva-
tion in RQ values of greater magnitude and; a greater expiration- of 
c14o2 in adrenalectomized anima'l.s, pointing out that there is an 
increase in carbohydrate utilization in the adrenalectomized subject. 
In a later study Winterni tz and Forrest ( 82) infused 2-C14 pyruvate 
for 90 minutes into normal and adrenalectomized rats. A large amount 
of highly active liver glycogen was formed in the normals but not in 
the adrenalectomized animals. It was suggested that the increased 
carbohydrate utilization following adrenalectomy may be secondary to 
the diminished glycogenesis and may occur over all available routes. 
_Goetsch_(28) demonstrated that corticoid treatment did not alter 
the rate of glycolysis in fed intact rats as evidenced by the fact 
that carbohydrate utilization was similar in liver homogenates 
from treated and non-treated rats and by the fact that inorganic 
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phosphate levels were similar in treated and control liver homogenates 
incubated under nitrogen. 
Inorganic phosphate level is often used as an indicator of gly-
colytic and respiratory rates. Mills and Thomas (60) noted that the 
inorganic phosphate concentrations in plasma and in whole blood are 
about the same and fall in a similar manner after the intravenous in-
jection of cortisol. No consistent changes in glucose have been found 
to accompany the phosphate uptake (60). 
Ashmore et al. (3) observed that the adrenal cortical steroids 
had no effect on the phosphogluconate oxidation pathway. 
GLUCONEcx;ENESIS 
The conditions under which the corticosteroids exert their in-
fluence are largely those in which the animal is forced to form 
glucose from pro~ein. An excess of these hormones always accelerates 
protein catabolism in such circumstances as fasting, insulin 
hypoglycemia and pancreatic diabetes (56). Long et al. (57) 
in 1940 suggested that one of the properties of the cortical 
hormones is the stimulation of protein catabolism and that the 
increase in carbohydrate levels and nitrogen excretion following 
their injection is an expression of this effect. Results of Ingle 
and coworkers (37) indicated that the effect of the C-11-17 
oxgenated cortical steroids in stimulating protein catabol i sm 
was not prevented or significantly diminished by insulin. 
Welt et al . (79) found that cortisone treatment caused a 
7-fold increase in the production of glucose synthesized per hour 
from non- carbohydrate precursors over untreated controls and a 
2-fold increase over normal in glucose production in alloxan 
diabetic rats . Administration of cortisone and glycine produced 
an increase in liver glycogen of "fasted normal rats ( 32) . 
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Rosen et alo (69) 9 in an attempt to find an enzymatic basis for 
the gluconeogenic action of hydrocortisone demonstrated that chronic 
injections of 5 mg. of compound F daily for 7 days caused an increase 
of 500 percent in glutamic-pyruvic transaminase activity in rat livers. 
A slight increase in activity of glutamic-oxalacetic transaminase 
was also notedo These results strongly suggest that the glucocorticoids 
increase gluconeogenesis and impose a negative nitrogen balance by 
enhancing the transamination processes. Increased transaminase activity 
would be expected to alter the rate at which precursors of protein 
are interchanged with carbohydrate intermediates. These same workers 
made a further study of the increase in activity of glutamic-pyruvic 
transaminase in four conditions associated with gluconeogenesis (70). 
The conditions were the administration of corticosteroids, alloxan 
diabetes, fasting, and an elevated protein diet. In each instance 
there was a marked increase in the activity of liver glutamic-pyruvic 
transaminase gluconeogenic, suggesting an involvement of new enzyme 
synthesis rather than an activation of the enzyme. Brin and McKee (13) 
reported that cortisone treatment resulted in an increase ?nd adrenal-
ectomy in a decrease in transaminase activity in rat livers~ 
The effects of cortisol on liver glycogen deposition and glutamic-
pyruvic transaminase gluconeogenic activity were studied in vitamin B6 
deficient and control rats by Einsenstein (24). It was found that 
the glucocorticoid action of cortisol is diminished in vitamin B6 
depleted animals as is the effect of the hormone on transaminase activity. 
Other parameters of cortisol action such as involution of lymphoid 
tissue were unaltered by the vitamin deficiency. It was concluded 
from this work that the gluconeogenic activity of the 
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adrenal corticoids depends not only on their molecular configuration 
but also upon the nutritional status of the animal. 
The gluconeogenic activity of these steroid hormones has also 
been demonstrated in extranepatic tissues. Landau (48) incubated 
pyruvate-2-c14 with rat kidney slices from normal, alloxan-
diabetic, and cortisone-treated animals. This study showed: 
that pyruvate uptake and tne incorporation of c14 into glucose and 
lactate were greater than normal in the diabetic and cortisone-
treated groups; that incorporation of c14 into glycogen was in-
creased above normal in the cortisone-treated animals; a several 
fold increase in glucose content in the diabetic and steroid 
treated slices; and that a large percentage of this newly 
formed glucose was synthesized from pyruvate carbon. 
Segaloff and Many (72), using phloridizinized rats, showed 
that ACTH, 11-dehydrocorticosterone, corticosterone, cortisone, 
an~ hydrocortisone increased glycosuria and ketonuria in ex-
cess of what could be accounted for on the basis of the accom-
panying increase in nitrogen excretion; therefore, it was 
concluded that the rat is capable of deriving glucose from 
fat as well as protein. Cortisone has an antagonistic action 
on hepatic lipogenesis in intact animals (12). Chronic adminis-
tration of ACTH or cortisone caused glycosuria and acetonuria 
in rats force fed on a high fat, low carbohydrate diet and 
cortisone induced glycosuria without acetonuria in rats on a 
medium carbohydrate diet (35, 36). 
Mokrasch et al. (61) found an increase in liver fructose-
1, 6-diphosphatase activity in rabbits fed diets low in glu-
cose but rich in protein or in fructose. A large increase in 
the enzyme content was obtained by the administration of corti-
sone. It was suggested that the observed increases represent a 
physiological means of causing increased gluconeogenesis in 
response to the stress imposed. 
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CHAPTER III 
MATERIALS AND METHODS 
Mature female albino rats (Sprague-Dawley strain), weigh-
ing 300 to 350 gm. were used as the experimental animals and 
were given free access to feed (Purina Rat Chow) and water 
both before and after treatment. They were housed at a tempera-
ture varying from 60°F to 75°F. Prednisolone ( "Sterane", 
Pfizer) ( ~F), a synthetic adrenalcortical hormone having 
strong glucocorticoid properties, was used in this study. 
Immediately following sacrifice by decapitation the left 
half of the median lobe of the liver was removed and placed 
in 9 ml. of isotonic KC! cooled to Oto 5°c. The isotonic 
KCl and liver sample were than transferred to an ice-chilled 
Potter-Elvehjem homogenizer and considered homogenized after 
5 to 8 passes with the plunger. One and one-half ml. of the 
homogenate were pipetted into a Warburg flask which contained 
1.5 ml. of phosphate buffer and 0.2 ml. of 25% KOH in the center 
well. A fluted piece of filter paper was placed in the center 
well of the Warburg flask to increase the absorption area for 
the carbon dioxide given off during incubation. A stock solu-
tion of the phosphate buffer was made by dissolving 9.92 gm. 
potassium chloride. 1.35 gm. magnesium thlOride, 0.91 gm. 
potassium acid phosphate in 800 ml. of distilled water, 
16 
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adjusting to pH 7.5 with potassium hydroxide and/or phosphoric acid 
and diluting to one liter (28). A 2 cc. syringe and 18 gauge 
needle were used for placing the KOH in the center well before 
putting the fluted filter paper in place. To further insure 
cold conditions, the Warburg flask was placed in a deep freeze 
for 15 minutes prior to the addition of the homogenate. 
Following the addition of the homogenate to the Warburg 
flasks, they were placed on manometers and flushed with oxygen 
for five minutes. The manometers were then transferred to a 
constant temperature bath at 37°c and allowed to equilibrate 
for 8 minutes. Readings were taken thereafter every ten minutes 
for 30 minutes to determine oxygen uptake. Dry liver weight 
was determined by putting 1 ml. of the homogenate in a small 
tared container and drying in an oven for 12 to 24 hours at 
150°c. After drying, the tared containers were weighed back 
on a Roller-Smith torsion balance. 
In experiment I, stimulation of respiration was used as 
the criterion for determining the optimum dose of prednisolone. 
To each of three groups, ~F was randomly administered i.m., 
five hours before sacrifice, in quantities of 0.5 mg., 5.0 mg., 
and 20.0 mg. A fourth group served as a control and received 
1 ml. of physiological saline (PSS) i.m. five hours before 
sacrifice. Oxygen uptake by the liver homogenate and the dry 
liver weight were determined as described above. 
Experiment II was designed to learn the time interval 
following the steroid injection when maximum oxygen uptake 
occurred in incubating liver homogenates. Groups were assigned 
at random to receive 5.0 mg. of 6. 'F at 8 hours, 4 hours, 2 hours, 
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and l hour prior to sacrifice. The control group was injected i.m. 
with 0.5 ml. of physiological saline 8 hours before sacrifice. 
Experiment III was used to ascertain the effect of prednisolone 
on hepatic carbohydrate utilization and respiration in liver homo-
genates prepared from intact, from adrenalectomized, and from 
(24 hours) fasted-adrenalectomized rats. Four groups of intact 
animals (15 per group) were assigned at random to the following 
treatments: 0.5 ml. of physiological saline, 400 mg. of glucose, 
5.0 mg. of .~ 1 F3 and 400 mg. of glucose plus 5.0 mg. of~'F. 
The same sequence of treatments was repeated in four groups 
(15 rats per group) of adrenalectomized animals9 and in four 
groups (10 rats per group) of fasted-adrenalectomized rats. 
The synthetic glucocorticoid and physiological saline in-
jections were made intramuscularly while the glucose was ad-
ministered intraperitoneally. Oxygen uptake was determined 
as previously described 3 and reducing glucolytic intermediates 
and liver glycogen were determined for each animal both before 
and after incubation. The term, reduoiD9 glyc6lytic intermediates, 
as used here includes glucose and any glycolytic intermediates 
that have a free or potentially free aldehyde group. 
Adrenalectomies were performed five to seven days prior to 
use in these studies; the animals were maintained on one percent 
sodium chloride drinking water. 
To determine reducing glycolytic intermediates (expressed 
as grams percent of glucose), a protein-free filtrate was first 
prepared from the liver homogenate by the addition of 1 ml. of 
0.3N barium hydroxide to 1 ml. of homogenate. After a brownish 
color developed, 1 ml. of 10 percent zinc sulfate was added 
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followed by 7 ml. of distilled water. The mixture was then centri-
fuged at 3000 r.p.m. for 15 minutes, filtered, and stored in a 
deep freeze. Later the filtrate was thawed and 1 ml. of it was sub-
jected to Nelson's (62) photometric adaptation of the Somogyi Method 
for determination of glucose. One ml. of the filtrate was pipetted 
into a Folin-Wu blood sugar tube graduated at 25 ml. To this was 
added l ml. of a mixture (prepared the day of use) of 25 parts of 
Nelson's reagent A to 1 part of Nelson's reagent B. Standards and 
1 ml. of distilled water, which served as a blank, were set up in 
the same manner. The solutions were mixed and heated for 20 
minutes in a boiling water bath. After cooling the tubes in a pan 
of running tap water, l ml. of the arsenomolybdate color reagent 
was added to each tube. The mixture was then diluted to the 25 ml. 
mark with distilled water and read at 540 my on a Coleman Jr. 
Spectrophotometer. The color which develops Ls very stable and 
can be read at convenience (62). 
Liver glycogen isolation was accomplished by placing 1 ml. of 
liver homogenate and 1 ml. of 30 percent potassium hydroxide 
in a 12 or 15 ml. centrifuge tube and then placing the tube in a 
boiling water bath for 20 minutes. At the end of 20 minutes, 7 ml. 
of 95 percent ethyl alcohol was added and the tubes were returned 
to the water bath until the mixture just began to boil. Then the 
tubes were removed, allowed to cool at room temperature, and 
centrifuged at 3000 r.p.m. for 15 minutes. After the alcohol was 
decanted off, leaving only precipitated glycogen, the tubes were 
stored in a deep freeze. Later they were removed, thawed, the 
glycogen resuspended in 10 ml. of lN sulfuric acid, and hydrolyzed 
in a boiling water bath for 3 to 4 hours. The hydrolysate, following 
neutralization with lN sodium hydroxide until a yellow color was 
obtained with phenol red indicator, was then analyzed for glucose 
by the Nelson method and liver glycogen values were expressed as 
grams percent of glucose. 
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Chemicals used in the preparation of the Nelson's reagent were 
of the analytical grade. Copper reagent A was prepared by dissolv-
ing 25 gm. of anhydrous sodium carbonate, 25 gm. of Rochelle salt 
(potassium sodium tartarate), 20 gm. of sodium bicarbonate, and 
200 gm. of anhydrous sodium sulfate in 800 ml. of water and di-
luted to one liter. The solution was stored where the temperature 
did not fall below 20°c. Copper reagent B was made from 15 per-
cent cupric sulfate containing one or two drops of concentrated 
sulfuric acid per 100 ml. of water. The arsenomolybdate color 
reagent was prepared by dissolving 25 gm. of ammonium molybdate 
in 450 ml. of distilled water, to which was added 21 ml. of con-
centrated sulfuric acid and mixed, followed by the addition of 3 gm. 
of disodium arsenate dissolved in 25 ml. of water, mixed again 
and incubated at 37°c for 48 hours. This reagent was stored in 
a brown bottle in a dark place. The zinc sulfate and the barium 
hydroxide solutions were adjusted so that 5 ml. of zinc sulfate 
required between 4.7 ml. and 4.8 ml. of barium hydroxide to pro-
duce a definite pink to phenolphthalein. The zinc sulfate was 
diluted to 20 ml. with water and the barium hydroxide was added 
dropwise during the titration. 
The studentus "t" test was used to analyze the data in experi-
ment I. An analysis of variance (AOV) was performed on all other 
data in these experiments and was followed by a Tukeyus D test to 
locate the differences among the means. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Prednisolone ( ~ 'F) differs structurally from the naturally 
occurring adrenal cortical hormone, hydrocortisone (compound F), 
in having an unsaturated bond between carbons 1 and 2. This de-
hydrogenation gives to the 
CH20H 
6=:o 
-OH 
Predni so lone 
prednisolone molecule an exaggerated 
CH20H 
I 
C=O 
- OH 
0 
Hydrocortisone 
glucocorticoid activity (64). The elevated glucocorticoid activi-
ty of prednisolone may also be attributed to the long plasma half .. 
life, 204-241 minutes, as compared to that of hydrocortisone, 113 
minutes (64). Apparently, because of this alteration .in the 
molecular structure, prednisolone is metabolized much more slowly 
by the liver when compared to .the naturally occurring hormone. 
Microliters of oxygen taken up by the rat liver homogenates 
from experiment I are shown in Table I and illustrated graphically 
by Fig. 1. Intramuscular administrations of varying doses of 
-prednisolone were made five hours prior to sacrifice to determine 
the optimum dose of the synthetic hormone. The control group 
received 1 ml. of PSS at the same time interval. Preliminary 
experiments indicated that sham injections of PSS did not affect 
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Figure 1. Average oxygen uptake (pl/mg. dry liver) by rat 
liver homogenates expressed as microliterf 0 
taken up per mg. liver on a dry weight basis? 
Rats were treated i.m. with different levels of 
prednisolone 5 hours before sacrifice. 
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TABLE I 
AVERAGE OXYGE N UPTAKE BY RAT LIVER HCMOGENATES EXPRESSED AS MICRO-
LITERS OF OXYGEN TAKEN UP PER MG. OF DRY LIVER. RATS WERE 
TREATED I.M. WITH DIFFERENT LEVELS OF PREDNISOLONE 5 
Group 
No. 
HCXJRS BEFORE SACRIFICE 
Treatment No. of Rats Incubation Time (minutes) 
10 20 
23 
1 
2 
3 
4 
1 ml. PSS 
0.5 mg. ~' F 
5.0 mg. 6 'F 
10 13.0 24.l 31.2 
10 14.6 25.8 33.3 
10 15.9 30.1 39.2 
20.0 mg. 6 'F 10 16.1 31.1 41.2 
Student's t-test: At 10 minutes, P = 0.025, 3<1; at 20 minutes, 
P = 0. 05 , 3 < 1 ; at 3 0 minutes , P = 0. 10, 3 <.l . 
the respiration of rat liver homogenates. Five milligrams and 20.0 
mg. of prednisolone caused a significant increase at each of the ten 
minutes intervals of incubation (P = u.025 at 10 min., P = 0.05 at 
20 min., P = 0.10 at 30 min.). The 20.0 mg. dose caused a slightly 
greater stimulation of respiration than did the 5.0 mg. dose; however:, 
the difference was statistically significant. As the incubation 
time increased, the difference in oxygen uptake between the control 
and treated groups increased, but because of the wider sample varia-
tion at the end of 30 minutes, the differences were statistically 
less significant. It is apparent from these results that, under 
the condit i ons used in this experiment, 5.0 mg. of L} 'F is sufficient 
to stimulate near maximum respiration and that additional predniso-
lone will not further increase oxygen consumption to any great 
extent. 
Once t he optimum treatment l evel was determi ned, i t s eemed 
desirable to find out the time interval following the admini stration 
/ 
of prednisolone when maximum response occurs. The greatest stimulation 
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of respiration by liver homogenates from rats previously treated 
with 5.0 mg. <0i'F occurred four hours after the injection (Table II 
and Fig. 2). Oxygen uptake was significantly increased (P = 0.01) at 
both two and four hours after treatment. Respiration in the four 
hour group was also significantly greater than in the two hour group. 
Eight hours after treatment respiration was no longer stimulated to the 
extent noted in the two and four hour groups. This is further evi-
denced by oxygen uptake values not greatly increased over normal 
values. It is concluded from these findings that the biochemical 
reactions causing increased oxygen uptake are occurring to the 
greatest extent at approximately four hours after i.m. glucocorticoid 
administration and that the capacity of this synthetic steroid to 
stimulate respiration is practically non-existant eight hours after 
treatment of normal rats. 
TABLE II 
AVERAGE OXYGEN UPTAKE BY RAT LIVER HOMOGENATES EXPRESSED AS MICRO-
LITERS OF OXYGEN TAKEN UP PER MG. OF DRY LIVER. RATS WERE 
TREATED I.M. WITH 5.0 MG. OF PREDNISOLONE AT VARIOUS 
TIME INTERVALS BEFORE SACRIFICE 
Hours Incubation Time Group After No. of (Minutes) No. Rats Treatment 10 20 30 
1 0 10 9.9 17.5 21.4 
2 1 10 13.6 23.2 29.0 
3 2 10 15.1 27.3 36.5 
4 4 10 16.1 29.8 40.2 
5 8 10 13.1 23.7 30.9 
AOV-Tukey's D test: at 10 and 20 minutes, p = .01; 4, 3> l; at 30 
minutes P = 0.01; 3, 4 >l; P = 0.05; 4>5. 
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Figure 2. ,Average oxygen uptake (pl/mg. dry liver) by rat liver homogenates expressed as 
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To ascertain the effect of prednisolone on hepatic carbohydrate 
utilization and respiration in liver homogenates prepared from in-
tact, from adrenalectomized, and from (24 hrs.) fasted-adrenalectomi-
zed rats, 160 rats were assigned at random to one of the following 
treatments: U.5 ml. of physiological saline, 400 mg. of glucose, 
5.0 mg. ~'F, or 400 mg. glucose plus 5.0 mg. ~'F. This sequence 
of treatments was administered to intact, to adrenalectomized, and 
to fasted-adrenalectomized animals. 
It is evident from Table III and Figures 3, 4, and 5, that 
these treatments resulted in some marked changes in the respiration 
of the liver homogenates. As in Experiments I and II, prednisolone 
caused a significant increase (P = 0.05) in oxygen consumption, 
during 30 minutes incubation, by liver homogenates prepared from 
rats with intact adrenals (Fig. 3). The singular administration 
of glucose to intact rats caused a slight depression of respiration. 
Prednisolone and glucose, when given jointly to intact rats, 
caused a marked stimulation of oxygen consumption (Fig. 3.). When 
given alone or with glucose, prednisolone caused a significant in-
crease (P = o.ul) in respiration of homogenates pr.epared from 
livers of adrenalectomized animals when compared to the adrenalec-
tomized controls or intact controls. This can best be seen in 
groups 5 through 8 in Table III and in Fig. 4. Glucose by itself 
did not affect oxygen uptake in the adrenalectomized groups. 
In the fasted-adrenalectomized rats, as in the adrenalectomized 
groups, prednisolone when given singularly or jointly with glucose 
significantly stimulated (P = 0.01) respiration by the liver homo-
genates (Table III and Fig. 5). However, it is interesting to note 
that when these two treatments were given together, the stimulation 
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TABLE III 
AVERAGE OXYGEN·UPTAKE BY RAT LIVER HCMOGENATES EXPRESSED AS MICRO-
LITERS OF OXYGEN TAKEN UP PER MG. OF DRY LIVER. GROUPS 1-4 WERE 
INTACT, GROUPS 5-8 WERE ADRENALECTCMIZED, AND GROUPS 9-12 WERE 
FASTED-ADRENALECTOMIZED. TREATMENTS WERE ADMINISTERED 4 
HOURS BEFORE SACRIFICE 
Treatment 
0.5 ml. PSS 
400 mg. glucose 
5.0 mg. 6 'F 
glucose & 6' F* 
0.5 ml. PSS 
400 mg. glucose 
5.0 mg. 6,'F 
glucose & 6' F* 
0.5 ml. PSS 
400 mg. glucose 
5.0 mg. ~'F 
glucose & 6'F* 
Group No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
LO 
11 
12 
*400 mg. glucose and 5.0 mg. b.'F 
No. of 
Rats 
15 
15 
15 
15 
15 
15 
15 
15 
10 
10 
10 
10 
Incubation Time 
{mirtutes) 
10 20 30 
14.3 26.l 32.9 
13.4 23.7 27.8 
15.4 30.8 .,,40.9 
17.5 33.4 43.9 
13.2 23.2 28.9 
14.0 24.l 29.9 
17.6 31.4 40.1 
16.8 29.9 38.2 
10.0 16.0 21.4 
7.0 12.9 16.4 
16.0 28.8 36.1 
17.0 28.l 32.5 
AOV-Tukey's D test: At 10 minutes; P = 0.01; lO<all other groups, 
9<all other groups except 10; 5<4, 7, 8, 11, 12; 2, 6<4, 7, 8, 
12; l <4, 7, 12. P = 0.05; 1 <8; 2 <11. At 20 minutes: P = 0.01; 
9, 10 <all other groups; 2, 5<3, 4, 7, 8, 11; 6<"3, 4, 7, 8; l <4., 
7; 11, 12<4. P = 0.05; 2, 5<12; 6 <11; 1<8. At 30 minutes; 
P = 0.01; 10 <l, 2, 3, 4, 5, 6, 7, 8, 11, 12; 9< 1, 2, 3, 4, 5, 6, 
7, 8, 11, 12; 2, 5<3, 4, 7, 8, 11; 6<3, 4, 7, 8; 1<4, 7; 11, 12<4 •. 
P = 0. 05; 2, 5 < 12; 1 < 3. 
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Figure 3. Average oxygen uptake (pl/mg. dry liver) by liver 
homogenates prepared from intact rats expressed as 
--""'\ mic:oli ters o2 taken up per mg. liver on a dry weight 
\basis. 
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of respiration was slightly less than when prednisolone was adminis-
tered singly. 
Glucose injections into fasted-adrenalectomized rats resulted 
in a significant decrease (P = 0.01) in respiration as compared to the 
intact or adrenalectomized controls and to intact or adrenalectomized 
groups to which glucose was administered (Table III). The apparent 
decrease in oxygen consumption observed between the fasted-adrenalec-
tomized controls and the fasted-adrenalectomized animals receiving 
glucose was not statistically significant. It is, therefore, con-
cluded that the marked depression observed in the glucose-treated, 
fasted-adrenalectomized animals is an expression of the fasting 
state. However, the possibility remains that glucose treatment may 
have further increased the depression in respiration. 
Consideration of all twelve groups in Table III and Figures 3, 
4, and 5 reveal that ablation of the adrenal had litt le if any effect 
on respiration of the rat liver homogenates. Furthermore, predni-
solone when administered singly or in conjunction with 400 mg. of 
glucose elicited approximately the same respiratory response in 
adrenalectomized or intact rats. A comparison of all twelve groups 
also indicates that the 24 hour fast resulted in a significant redu c -
tion (P = 0.01) of respiration and that prednisolone can restore 
respiration in fasted-adrenalectomized ~ats to approximately the 
values observed in intact or adrenalectomized animals treated similarly . 
Previous workers (28, 29, 30, 41) have reported conflicting 
results concerning the respiratory-stimulating property of the 
glucocorticoids. The disagreement is resolved if the duration of the 
treatment is taken into consideration. The results observed herein 
do not agree with t hose reported by Kerpolla and Pitkanen (41), who 
demonstrated an inhibition of oxygen uptake by liver mitochondria 
from rats treated chronically with cortisone; the decrease was 
noted at the cytochrome c oxidase portion of the respiratory chain. 
The results reported herein do agree with the findings of Goetsch 
(28,29) and Grossfeld (30). A single injection of prednisolone 
five hours previous to sacrifice stimulated respiration of rat 
liver homogenates (28, 29) . The stimulation of oxygen consumption 
was demonstrated by Grossfeld (30) in mouse fi broblast tissue 
cultures to which 1 . 5U ug. of hydrocortisone was added at 96 , 24, 
and O hours oefore the manometric experiments. 
Concurrently with the determination of oxyg en uptake, values 
for the reducing glycolytic intermediates (Tabl e IV) and glycogen 
(Table V) ,were determined both 1bef0re and after the thirty min-
utes incubation period. Total carbohydrate values (Table VI) 
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were obtained by adding the va1ues for the reducing g1yco1ytic 
intermediates to the values for glycogen both be fore and after incu-
bation. This was done to learn the effect of predniso1one on liver 
carbohydrate utilization and to investigate the possibility that 
there might be some relationship between carbohydrate disappearce 
or utilization in the liver and the enhanced homogenate respiration 
noted following predniso1one treatment. 
The reducing glycolytic intermediates (Table IV) include glu-
cose and any other glyco1ytic intermediate with a free or potentially 
free aldehyde group and were determined to obtain, when added to 
glycogen determinations, total carbohydrate values. No treatment 
effects were noted on the preincubation values for reducing g1ycolytic 
intermediates in adrenalectomized groups. A significant decrease 
(P = O. vl) in these values for homogenates from fasted-adrenalectomized 
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TABLE IV 
SUMMARY OF AVERAGE REDUCING GLYCOLYTIC INTERMEDIATE VALUES (EXPRESSED 
AS GM.% OF GLUCOSE) IN EXPERIMENT III. GRctJPS 1-4 WERE INTACT, 
GROUPS 5-8 WERE ADRENALECTOMIZED, AND GRCJJPS 9-12 WERE FASTED-
ADRENALECTOMIZED. RATS WERE TREATED 4 HCJJRS BEFORE SACRI-
FICE. DETERMINATIONS WERE MADE BEFORE AND AFTER 30 
MINUTES INCUBATION UNDER OXYGEN 
Group Treatment No. Preincu- Postincu- Di ff er-
No. of bat ion bat ion ence Rats 
1 0.5 ml. PSS 15 2.00 4.44 2.44 
2 400 mg. glucose 15 2.07 4.17 2.10 
3 5.0 mg. 6 1 F 15 1.97 5.00 3.03 
4 glucose and 6'F* 15 2.29 4.78 2.49 
5 0 . 5 ml. PSS 15 2.01 4.04 2.03 
6 400 mg. glucose 15 1.87 3.92 2.05 
7 5.0 mg. 6'F 15 2.12 4.73 2.61 
8 glucose and 6'F* 15 2.00 4.55 2.55 
9 0 . 5 ml. PSS 10 0.82 1.39 0.57 
10 400 mg. glucose 10 0.88 1.56 0.68 
11 5.0 mg. 6'F 10 1.06 1.85 0.79 
12 glucose and 6'F* 10 1.15 2.73 1.58 
* 400 mg. glucose and 5.0 mg. 6'F. 
AOV-Tukey's D test: 
Preincubation: P = 0.01; 9, 10, 11 J 12 <l, 2, 3, 4, 5, 6 , 7, 8; 
6 <4 . 
Difference: p = 0.01: 9, 10, 11<1, 2, 3, 4, 5, 6, 7, 8, 12; 
2, 5, 6<3; 12< 1, 3, 4, 7, 8; p = 0.05: 1, 4<3; 5, 6< 7. 
rats prior to incubation was observed; this undoubtedly was due to 
the fasting condition. Prednisolone singly or with glucose enhanced 
the appearance of reducing glycolytic intermediates during incubation 
in all three types of rats. 
There were no statistically significant differences in the pre-
incubation glycogen values within the intact groups except that pred-
nisolone treatment increased liver glycogen (P = 0.05) over the glu-
cose treated group (Table V). The lack of statistical significance 
is probably due to the wide variation in liver gl ycogen values of the 
individual rats. This is not surprising in view of the well known 
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TABLE V 
SUMMARY OF AVERAGE LIVER GLYCOGEN VALUES (EXPRESSED AS GM.% OF GLU-
COSE) IN EXPERIMENT III. GR OUPS 1-4 WERE INTACT, GROUPS 5-8 
WERE ADRENALECTCMIZED, AND GROU PS 9-12 WERE FASTED-ADRENAL-
ECTCMIZED. TREATMENTS WERE ADMINISTERED 4 HOURS BEFORE 
SACRIFICE. DETERMINATI ONS WERE MADE BEFORE AND AFTER 
30 MINUTES INCUBATI ON UNDER OXYGEN 
No. Group Treatment 
of Preincu- Postincu- Differ-No . Rats bation bation ence 
1 0.5 ml. PSS 15 
2 400 mg • glucose 15 
3 5.0 mg. .6'F 15 
4 glucose and .6'F* 15 
5 0.5 ml. PSS 15 
6 400 mg. glucose 15 
7 5.0 mg. 6 1 F 15 
8 glucose and .6'F* 15 
9 0.5 ml. PSS 10 
10 400 mg . glucose 10 
11 5.0 mg. D.'F 10 
12 gluco se and D.'F* 10 
*400 mg. glucose and 5.0 mg. ~'F 
AOV-Tukey's D Test: 
9.86 7.52 
7 .17 4.16 
10.90 7.26 
8.94 7.04 
9.41 6 .34 
8.02 6 .35 
9 .26 7.68 
11.05 9.34 
1.65 1.62 
1. 74 1.6 
3.14 1. 79 
4.68 2.68 
Preincubation: P = 0.01: 9, 10, 11, 12 <l , 3, 4, 5, 7, 8; 
9, 10, 11 < 2, 6 . P = 0. 05: 2 < 3, 8. 
2.34 
3.01 
3. 64 
1.90 
3.07 
1.66 
1.57 
1. 71 
0.03 
0.08 
1.35 
2.00 
fact that liver glycogen fluctuates greatly over a 24 hour period. 
However, it is of interest to note that prednisolone did increase 
the glycogen levels in intact animals. This is in agreement with 
numerous reports stating that the glucocorticoids in~rease liver gly-
cogen deposition (6, 14, 16, 33, 50, 57, 84). Clark and Pesch (16 ) 
explained the increased glycogen levels in cortisone treated animals 
on the basis of a partial block at some point in the Krebs cycle, 
This was concluded from the observation that cortisone inhibited the 
oxidation of alpha-ketoglutarate by liver mitochondria even though 
the P/0 ratios remained within normal ranges. 
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TABLE VI 
SUMMARY OF AVERAGE TOTAL CARBOHYDRATE VALUES (EXPRESSED AS GM.% OF 
GLUCOSE) I N EXPERIMENT III. GROJPS 1-4 WERE INTACT, GROJPS 5-8 
WERE ADRE NALECTCM IZED, AND GROUPS 9-12 WERE FASTED-ADRENALEC-
TO\HZED, TREATMENTS WERE ADMI NISTERED 4 HOURS BEFORE SAC-
RIFICE. DETERMINATIONS WERE MADE BEFORE AND AFTER 30 
MI NU TES INCUBATION UNDER OXYGEN 
Group No, 
No, Treatment of Preincu- Postincu- Di ff er-
Rats bat ion bat ion ence 
1 0.5 ml. PSS 15 11.85 11.62 0.23 
2 400 mg. glucose 15 9.24 8.33 0.91 
3 5.0 mg. 6 ' F 15 12.87 12.27 0.60 
4 glucose and 6'F* 15 11.23 11.81 -0.59 
5 0.5 ml. PSS 15 11.40 10.25 1.15 
6 400 mg. glucose 15 9.89 10.27 -0.38 
7 5.0 mg. 6'F 15 11.37 12.41 -1.04 
8 glucose and 6'F* 15 13.06 13.89 -0.83 
9 0.5 ml. PSS 10 2.47 3.01 -0.54 
10 400 mg. glucose 10 2.62 3.22 0.60 
11 5.0 mg. 6'F 10 4.20 3.64 0.56 
12 glucose and 6'F* 10 5.82 5.33 0.49 
*400 mg. glucose and 5.0 mg. ~'F 
AOV-Tukey' s D test: 
Preincubation: P = 0.01: 9 , 10, 11<1, 2, 3, 4, 5, 6 , 7, 8; 12< 1, 
3, 4, 5, 6 , 7, 8; P = 0.05: 2<3, 8; 12 <2. 
Within the adrenalectomized groups there was also a lack of 
statistically significant differences in the preincu bation glycogen 
values (Table V). Prednisolone when given with glucose did cause a 
noticeable increase in liver glycogen before incubation in the 
adrenalectomized and the fasted-adrenalectomized rats. The results 
suggest that adrenalectomy tended to decrease glycogen deposition when 
adrenalectomized controls are compared to intact controls. This ob-
servation is in accord with the well known fact that the glucocorti-
COQdS enhance liver glycogen deposition. Equally apparent is the 
fact that the administration of prednisolone in addition to glucose 
tends to restore liver glycogen deposition in adrenalectomized rats. 
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In fasted-adrenalectomized animals one would expect to find less 
variation in the liver glycogen levels and thus a more valid evaluation 
of the effects of prednisolone and/or glucose administration should 
be obtained from these animals. As would be expect~d, fasting re-
1 
sulted in a marked drop (P = 0.01) in liver glycogen values in all 
four fasted-adrenalectomized groups when compared with intact or 
adrenalectomized animals. 
Treatment effects on liver glycogen deposition were not signifi-
cant within the fasted-adrenalectomized groups; however, glucose, 
prednisolone, or prednisolone and glucose treatments caused an 
elevation of liver glycogen in that order. 
No statistically significant treatment effects were obtained 
between any of the twelve groups in rate at which glycogen disappear-
ed during 30 minutes of incubation. 
To obtain the overall picture of carbohydrate utilization 
during incubation, total carbohydrate values were computed by 
adding the values for the reducing glycolytic intermediates 
and glycogen together both before and after incubation. The 
difference between preincubation and postincubation values were then 
recorded and appear in Table VI. It is apparent that fasting 
markedly decreased (P = 0.01) the total liver carbohydrate in the 
fasted-adrenalectomized groups prior to incubation. Similar trends 
are seen in the preincubation values for total carbohydrate (Table 
VI) of the intact and adrenalectomized groups. There were no 
statistically significant treatment effects on the rate at which 
the total carbohydrate was utilized in the liver homogenates during 
incubation. 
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The trend towards carbohydrate synthesis during incubation in 
groups 4, 6, 7, 8, 9 and 10 are difficult to explain; statistically 
they are not different from the groups showing utilization. In groups 
4, 7, 8, all of which received prednisolone, this increase in total 
carbohydrate could conceiveably represent gluconeogenesis. 
The trend towards increased carbohydrate utilization in the 
adrenalectomized control rats compared with the intact controls 
(Table VI) tends to confirm the results of Winternitz and Kline (83) 
who studied respiratory quotients and c 14o2 production from 2-c14-
pyruvate in adrenalectomized animals and reported an increase in 
carbohydrate utilization in the adrenalectomized subject. 
Since there were no treatment effects of prednisolone on 
total carbohydrate utilization to accompany the respiratory-
stimulating property, the cause of the enhanced respiration 
apparently does not lie in the area of carbohydrate metabolism 
studied in this experiment. This confirms earlier reports by 
Goetsch ("28). 
An explanation for the increased respiration following the 
administration of glucocorticoids may well lie in the process 
called respiratory chain phosphorylation or oxidative phosphory-
lation which may be depicted as follows (80). 
Oxidized 
Metabolite 
Metabolite DP 
H 0 
respiratory ( 2 
. chain 
0 
C YH< (ATP 
NYH~YNPJ ADP 
lip 
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In this process, three moles of ATP are formed as each pair of elec-
trons are passed from the metabolite up the respiratory chain to 
molecular oxygen. The phosphorylation of ADP to ATP is thus coupled 
through some unknown compound to the respiratory chain; thus, in 
a steady state condition inorganic phosphate (iP) and/or ADP may exert 
a regulatory-influence on the respiration process (51). 
Chronic treatment (7 days) with cortisone has been shown to 
uncouple oxidative phosphorylation in rat liver mitochondria (40). 
This could have conceively also occurred in the rat liver homogenates 
of this experiment following a single injection of prednisolone. 
This uncoupling would have released the regulatory influence of ADP 
and inorganic phosphate and allowed respiration to proceed at an 
increased rate. It has been shown that the rate of oxidation of 
ferrocytochrome tis increa~ed in.the presence of some uncoupling 
agents (63). A large proportion of tissue ATP is produced through 
oxidative phosphorylation; uncoupling of oxidative phosphorylation 
by the glucocorticoids could inhibit the production of ATP which 
may in turn result in an impairment of the hexokinase function, and/or 
the mobilization of glycogen from the tissues because of an inhibition 
of the activation of phosphorylase b to phosphorylase a. 
Whether the single injection of prednisolone uncoupled oxida-
tive phosphorylation can be neither confirmed nor denied from the 
results reported herein since no concurrent studies were made on 
the oxidative phosphorylation process. The hypothesis is offered 
only as a possible explanation. 
CHAPTER V 
SUMMARY AND CONCLUSIONS 
The conflicting reports which have been published concerning 
the respiratory stimulating property of both naturally occurring 
and synthetic glucocorticoids can probably be best accounted for on 
the basis of the variety of tissues used and the differences in the 
duration of the treatment. This study was carried out to further 
clarify the respiratory stimulating property of glucocorticoids 
and to determine any effects which these hormones may have upon 
hepatic glycolysis in rat liver homogenates. 
Mature female albino rats were used as the experimental animals. 
Prednisolone, a synthetic adrenal cortical hormone similar to natur-
ally occurring hydrococtisone, was used in this study because of 
its exaggerated glucocorticoid properties. 
In experiment I, stimulation of respiration was used as the 
dri terion for determining the optimum dose of prednisolone. 
Different doses of the synthetic hormone were administered i.m. at 
random to three groups of rats; a fourth group received i.m. in-
jections of PSS and served as the control. It was apparent from 
the results obtained under the conditions of this experiment that 
5.0 mg. of .6.'F is sufficient to stimulate near maximum respiration 
and that additional prednisolone will not significantly increase 
oxygen consumption. 
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Experiment II was designed to learn the time interval fol l owing 
the steroid injection when maximum oxygen uptake by the incubating 
liver homogenates occurred. Groups were assigned at random to re-
ceive 5.0 mg . of ~'Fat varying periods of time prior to sacrifice. 
Oxygen uptake was significantly increased (P = 0.01) at both two and 
four hours following prednisolone treatment, the greatest stimulation 
being at a four hour interval. Prednisolone failed to stimulate 
respiration at 8 hours post-treatment. It was concluded from these 
findings that the biochemical reactions causing increased oxygen up-
take are occurring to the greatest extent about four hours after 
glucocorticoid administration and that the capacity of this synthet i c 
steroid to stimulate respiration is practically non-existant eight 
hours after treatment in normal rats. 
Experiment III ascertained the effect of prednisolone on 
hepatic carbohydrate utilization and respirat io n in liver homogenates 
prepared from intact, from adrenalectomized, and from (24 hr.) fasted-
adrenalectomized rats. One hundred sixty rats were assigned at random 
to one of the following parenteral treatments: 0.5 ml of phys iol-
ogical sa line, 400 mg. of glucose, 5.0 mg. of!::, 'F, and 400 mg . of 
glucose plus 5.0 mg. of £:,'F. This sequence of treatments was in 
turn given to intact, to adrenalectomized, and to fasted-adrenalecto-
mized rats. Ablation of the adrena l had little, if any , effect on 
respiration of the rat l i ver homogenates. Prednisolone, when 
administered s ing l y or in conjunction with gluco se, elicited approx-. 
imately the same increas e (P = 0.01) in respiration in all three 
types of animals . The 24 hour f ast resulted in a significant r e-
duction (P = 0.01) of respiration; however, p+ednisolone treatment 
restored homogenate respiration to values similar to those observed 
for intact and adrenalectomized animals, treated similarly with 
prednisolone. 
41 
No treatment effects were noted on the preincubation values for 
reducing glycolytic intermediates in intact or in adrenalectomized 
groups. A significant decrease (P = 0.01) in the reducing glycolytic 
intermediates of the fasted-adrenalectomized rats prior to incuba-
tion of the homogenate was observed; this undoubtedly was due to 
the fasting condition. Prednisolone singly or with glucose en-
hanced the appearance of reducing glycolytic intermediates ~uring 
incubation. 
There was no significant difference in preincubation liver 
glycogen values between intact or adrenalectomized groups treated 
similarly. The fasted-adrenalectomized groupi exhibited a signi-
ficant decrease (P = 0.01) in preincubation glycogen when compared 
to intact and adrenalectomized.animals. 
A study of the total carbohydrate utilized during incubation 
revealed that the treatments given had no statistical1y signifi-
cant effects. Therefore, the respiratory stimulating property of 
the glucocorticoids does not appear to lie in this area of metabolism. 
It is suggested from the results of other workers that the gluco-
corticoids may uncouple oxidative phosphorylation, which in turn 
may release the regulatory influence of inorganic phosphate and/or 
ADP, thus permitting respiration to proceed at a more rapid rate. 
BIBLIOGRAPHY 
1. Abood, L. G. and J. J, Kocsis. Effect of ACTH on Glycogenesis 
and Glycolysis in Hypophysectomized Rats, Proc. Soc. 
Exptl. Biol. Med., 75:55 (1950). 
2. Altszuler, N., R. Steele, J. S. Wall, and R. C. deBodo. 
Effects of Adrenocortical Steroids on Carbohydrate 
Metabolism in Hypophysec~omized Dogs; Studies with c14-
labeled Glucose, Am. J. Physiol., 191:29 (1957). 
3. Ashmore, J ., G. F. Cahill, Jr., R. Hillman, and A. E. Renold. 
Adrenal .Cortical Regulation of Hepatic Glucose Metabolism, 
Endocrinol., 62:621 (1958). 
4. Ashmore, J., A. B. Hastings, and F. B. Nesbett. The Effect 
of Diabetes and Fasting on Liver Glucose-6-Phosphatase, 
Proc. Nat. Acad. Sci., 40:673 (1954). 
5. Ashmore, J., A. B. Hastings, F. B. Nesbett, and A. E. Renold. 
Studies on Carbohydrate Metabolism in Rat Liver Slices VI. 
Hormonal Factors Influencing Glucose-6-Phosphatase, J. 
Biol. Chem., 218:77 (1956) 
6. Ashmore,J., F. Stricker, W. C. Love, and G. Kilskeines. 
Cortisol Stimulation of Glycogen Synthesis in Fasted 
Rats, Endocrinol., 68:599 (1961) 
7. Bacila, M. and E. S. G. Barron. The Effect of Adrenal Cortical 
Hormones on the Anaerobic Glycolysis and Hexokinase Activity, 
Endocrinol., 54:591 (1954), 
8. Bennett, L. I. The Interrelation of Pituitary and Adrenal 
in the Control of Carbohydrate Levels in The Rat, 
.Endocrinol., 22:193 (1938),·. 
9, Bennett, L. I, and C.H. Li. The Effects of Growth Hormone and 
Adrenocorticotrophic Hormone on the Urinary Glucose and 
Nitrogen Excretion of Diabetic Rats, Endocrinol., 39:63 
( 1956). 
10. Blaylock; B, A,, E. Rothrock, and J, Slacks. Alloxan Diabetes 
Insulin and Adrenosine Phosphates of Liver, Am. J. Physiol., 
198:1063 {1960). 
42 
43 
11. Blecher, M, and A. White . Loci of Action of Adrenal Cortical 
Steroids in Anaerobic Glycolysis by Cell-free Prepara-
tions of Rat Lymphosarcoma, J. Biol, Chem., 235:282. 
(1960). 
12. Brady, R. O., F. D. W. Lukens, and S. Gurin . Synthesis of 
Radioactive Fatty Acids in Vl±to, and Its Hormonal 
Control, J. Biol. Chem., 193:459 (1951). 
13. Brin, M. and R. W. McKee. Effects of X-Irradiation, Nitrogen 
Mustard , Fasting, Cortisone, and Adrenalectomy on Transa-
minase Activity in the Rat, Arch. Biochem. Biophys., 
61 :384 ( 1956) . 
14. Britton, S. W. and H. Silverte. Effects of Cortico Adrenal 
Extract on Carbohydrate Metabolism in Normal Animals, 
Am. J. Physiol., 100: 693 (1932), 
15. Cahill, C. A., J. Ashmore, S. Zotter, and A. B. Has tings . 
Studies on Carbohydrate Metabolism in Rat Liver Slices: 
IX. Io,nic and Hormonal Effects on Phosphorylase and 
Glycogen, J. Biol . Chem., 224: 237 (1957). 
16 . Clark, J. H. and L.A. Pesch. Effects of Cortisone Upon 
Liver Enzymes and Pr9tein Synthesis, J. Pharmacol. 
Expt. Ther., 117:202 (1956). 
17. Cohen, L. H. Glucose Inhibition of Respiration in the 
Developing Retina, Fed. Proc., 16 :165 (1957) . 
18, Cohn, C., B. Katz, B. Huddlestein, M. Kilinsky, and R. Levine. 
Utilization of Carbohydrate by Extrahepatic tissues of 
the Adrenalectomized Dog, Am. J. Physiol, 170:87 (1952). 
19 . Colowick , S. P., G, T. Cori, and M. w. Slein. The Effect of 
Adrenal Cortex and Anterior Pituitary Extracts and Insulin 
on the Hexokinase Reaction, J. Biol . Chem ., 168: 583 (1947). 
20. Conn, J. W., L. H. Louis, and S.S. Fajans. The Probability that 
Compound F (17-hydroxycorticorterone) is the Hormone Pro-
duced by the Normal Human Adrenal Cortex, Science, 113:713 
(1951). 
21. Constantinides, P., C. Fortier, and F. R. Skeleton. The Eff ect 
of Glucose on the Adrenal Response to ACTH in Hypophy-
sectomized Rats, Endocrinol., 47:351 (1950). 
22 . Cori, G. I , and C. F. Cori. Glucose-6-Phosphatase of the Liver 
in Glycogen Storage Disease, J. Biol . Chem. , 199 : 661 (1952 ). 
23 . Cr abtree , H. G. Obs ervat i ons on Car bohydrate Metabol i sm of Tumors, 
Biochem . J., 23 :536 (1929). 
24. Eisenstein, A. B. Relationship of Vitamin B6 to Gluconeogenic 
Action of CortisoJ:, Endocrinol., 67 :97 (1960). 
25. Froesch, E. R., J. Ashmore, and A. E. Renold. Comparison of 
44 
Renal and Hepatic Effects of Fa-sting, Co rtisone Administra-
tion and Glucose Infusion in Normal and Adrenalectomized and 
Glucose Infusion in Normal and Adrenalectomized Rats, 
Endocrinol., 62 : 614 (1958). 
26. Foresch, E. R., A. I. Winegrad, A. E. Renold, and G. W. Thorn. 
Mechanism of the Glucosuria Produced by the Administra-
tion of Steroids with Glucocorticoid Activity, J. Clin, 
Invest., 37:524 (1958). 
27. Glenn, E. M., B. J. Bowman, R. B. Bayer, and C. E. Meyer. 
Hydrocortisone and Some of Its Effects on Intermediary 
Metabolism , Endocrinol., 69:386 (1961). 
28. Goetsch, D. D. Some Metabolic Effects of Glucocorticoids in 
Cattle and Rats. Doctor's Thesis~, Oklahoma State University, 
(1961 ).- -
29. Goetsch, D. D. and L. E. McDonald. Glucocorticoid Effects on 
Respiration and Metabolism of Rat Liver Homogenates, Am. 
J. Physiol., 202:343 (1962). 
30. Grossfeld, H. A. Action of Hydrocortisone on Respiration and 
Aerobic Glycolysis of Cultured Cells, Science, 127:148. 
( 1958). 
31. Herman, M. s. and E. R. Ramey. Effect of Hydrocortisone and 
Epinephrine on Glucose Uptake by the Rat Diaphragm, 
Endocrii"\~l. 67 :650 (1960). 
32. Hess, W. C. and I. P. Shaffran. Effect of Corti sone upon 
Formation of Liver Glycogen from Glycine, Proc. Soc. 
Exptl. Biol. Med., 83:804· (1953). 
33. Hess, W. C., I . P. Shaffran, and E. L. Everitt. Effect of Corti-
sone on Liver Phosphory lase Activity, Proc. Soc. Exptl~ 
Biol. Med., 103:695 (1960). 
34. Ingle, D. J. and R. C. Meeks. Compnrison of Some Metabolic and 
Morphologic Effects of Cortisone and Hydrocortisone Given 
by Continuous Injection to Rats, Am. J. Physiol., 170:77 
( 1952). 
35. Ingle, D. J., M. C. Prestrud, and C.H . Li. Effects of Admin-
istering Adrenocorticotrophic Hormone by Continupus 
Injection to Normal Rats, Am. J. Physiol., 166:165 . (1951). 
36. Ingle, D. J., M. C. Prestrud, and J. A. Negamis. Effects of 
Administering Large Doses of Cortisone Acetate to Normal 
Rats, Am. J. Physiol., 166 :171 (1951). 
/ 
45 
37. Ingle, D. J., R. Sheppard, J. S. Evans, -a-nd M. H. Kuizenga. 
A Comparison of Adrenal Steroid Diabetes and Pancreatic 
Diabetes in the Rat, Endocrinol., 37:341 (1945). 
38. Johnson, M. J. The Role of Aerobic Phosphorylation in the 
Pasteur Effect, Science, 94 :200 (1941). 
39. Kerppola, W. Inhibition of Phosphorylase with Cortisone and 
Its Activation with Adrenaline in the Rabbit, Endocrinol., 
51:192 (1952). 
40. Kerppola, W. Inhibition of Oxidat&ve ·Phospflunylation with 
Cortisone in Liver Mitochondria, Endocrinol., 67:252 
( 1960). 
41. Kerppola, w. and E. Pitkanen. The Action of Cortisone on 
Oxidative and Glycolytic Enzyme Activities in Ratst,of 
Different Age and Sex, Endocrinol., 67:162 (1960). 
42. Kostyo, J. L. Effect of Some Steroids on Glycogen Metabolism 
in Uteru s and Skeletal Mu scle, Proc. Soc. Exptl. Biol . 
Med ., 97:405 (1958). 
43. Kowalewski, K. and G. Belesi. Tissue Oxygen Consumption in 
Rats Treated with Co rtisone and with An Anabolic Androgen, 
Proc. Soc. Exptl . Biol . Med., 106:300 (1961). 
44. Kun, E. and D.R. Mccurley . Physiological Regulation of 
Phosphopyruvate Formation from 3-Phosphoglycerate in , 
Rat Tissues, Proc. Soc. Exptl. Biol. Med., 75:797 (195fl): 
45. Kvam, D. C, and R. E. Parks. Hydrocortisone-Induced Changes in 
Hepatic Glucose-6-Phosphatase and Fructose Diphosphata:se 
Activities, Am. J. Physiol., 198:21 (1960). 
46. Lacroix, E. and I. Leusen. The Influence of Cortisone on the 
Oxygen Consumptio n of Myocardium and Diaphragm Slices 
of the Rat, Arch. Internat1onales de Pharm. Ther., 114:103 
( 1958). 
47. Lacroix, E. and I. Leusen. The Influence of Cortisone on Sub-
strate Utilization by Rat Heart Slices, Acta. Endocrinol., 
31:324 (1959). 
48. Landau, B. R. Gluconeogenesi s and Pyruvate Metapolism in Rat 
Kidney, In Vitro, Endocrinol., 67:744 (1960). 
49. Langdon, R. G. and D. ~. Weakly . The Influence of Hormonal 
Factors and of Diet Upon Hepatic Glucose-6-Phosphatase 
Activitf, J. Biol . Chem ., 214:167 (1955). 
50. Langley, L. L. and C. H. Guenthorpe. Adrenal, Hypophyseal and' 
Pancreatic Hormones in the Liver Glycogen Response to Low 
Atmospheric Pressure, Am. J. Physiol., 191 :342 (1957). 
46 
51. Lardy, H. A. and H. Wellman. Oxidative Phosphorylation: Role 
of Inorganic Phosphate and Acceptor Systems in Co ntrol of 
Metabolic Rates, J. Biol. Chem., 195:215 (1952). 
52. Lee, L. E. Effect of Steroid Hormones on Rat Liver Pyruvic 
Oxidase, Fed. Proc., 17:262 (1958). 
53. Leonard, S. L. Glycogen Deposition in Different Skeletal Mu scles 
Induced by Cortisone and Estradiol, Endocrinol., 53:226 
(1953). 
54. Leonard, S. L. The Effect of Hormones on Phosphorylase Activity 
in Skeletal Muscle, Endocrinol., 60:619 (1957). 
55. Linke, A. Experimental Study of the Significance of Liver Glu-
cose-6-Phosphatase for Regulation of Carbohydrate Metabo-
lism, Med. Welt., 46:2475 (1960). 
56. Long, C. N. H. A Discussion of the Mechanism af Action of 
Adrenal Cortical Hormones on Carbohydrate and Proteiro 
Metabolism, Endocrinol., 30:970 (1943). 
57. Long, C. N. H., B. Katzin, and E. Fry. The Adrenal Cortex and 
Carbohydrate Metabolism, Endocrinol., 26:309 (1940). 
58. Long, C. N. Hand, F. D. 'w. Lukens.' The Effects of 
Adrenalectomy and Hypophysectomy upon Experimental 
Diabetes in the Cat, J. Exptl. Med., 63:465 (1936). 
59. Mills, J. N. and S. Thomas. The Influence of Hydrocortisone 
upon Phosphate Metabolism in Muscle, J, Physiol., 142:506 
( 1958). 
60 . Mills, J. N. and S. Thomas. The Influence of Adrenal Corticoids 
on Phosphate and Glucose Exchange ~tn Muscle and Liver of 
Man-,. J .. Physto1!, 148:227 ( 1959). 
61. Mokrasch , L. C., w. D. Davidson, and R. IV . McGilvery . The 
Response to Gluconeogenic Stress of Fructose-1-6-
Diphosphatase in Rabbit Liver, J. Biol. Chem., 222:17.9 
( 1956). 
62 . Nelson, N. A Photometric Adaptation of the Somogyi Method for 
the Determination of Glucose , J. Biol. Chem., 153 :375 ( 1944). 
63. Nielsen, B, O. and A. L. Lehninger. Phosphorylation Coupled to 
the Oxidation of Ferrocytochrome c, J. Biol. Chem ., 215:555 
( 1955 ). 
64. Nugent, C, A., K. Eik-Nes, and F. H. Tyler . A Comparative Study 
of the Metabolism of Hydrocortisone and Prednisolone, J. 
Clin. Endocrinol. and Metab., 19 : 526 (1959 ), 
65. Nemeth, A. M. Glucose-6-Phosphatase in the Liver of the Fetal 
Guinea Pig, J. Biol. Chem ., 209:773. (1954). 
47 
66._ Overall, B. G., S. E. Condon, and V. Petrow. The Effects of 
Hormones and Their Analogues Upon the Uptake of Glucose by 
Mouse Skin In Vitro, J. Pharm. and Pharmacol., 12:150 
(1960). 
67. Papper, S., L. Saxon, and H. C. Alpert. The Effects of Cortisone 
on the Ga lactose Tolerance Tests of Normal Men, J. Lab . 
Clin. Med., 50:394 (1957). 
68 . Renold, A. E., C. T. Teng, F. B. Nesbett, and A. B. Hastings. 
Studies on Carbohydrate Metabolism in Rat Liver. II. 
The Effect of Fasting and of Hormonal Deficiencies, J. Biol. 
Chem., 204:533 (1953). 
69 . Rosen, F., M. R. Roberts, L. E. Budnick, and C. A. Nichol. 
An Enzymatic Basis for the Gluconeogenic Action, of 
Hydrocortisone, Science, 127:287 (1958). 
70. Rosen, F., M. R. Roberts, and C. A. Nichol. Glucocorticoids 
and Transaminase Activity. I. Increased Activity of 
Glutamic-pyruvic Transaminase in Four Conditions Ass~ciated 
with Gluconeogenesis, J. Biol. Chem ., 234:476 (1959). 
71. Russell, J. A. and L. L. Bennett. Maint enance of Carbohydrate 
Levels in Fasted Hypophysectomized Rats Treated with Anterior 
Pituitary Extracts, Proc. Soc. Exptl. Biol. Med ., 34:406 
72. 
( 1936 ). 
Segaloff, A. and A. S. Many. 
301 (1951), As cited 
Proc. 2nd Clin. ACTH Conf ., I, 
in Rev. Physiol., 14:466 (1952). 
73. Topper, Y. J. and L.A. Persch. Galactose : Its In Vitro 
Oxidation as Influenced by Steroids, Fed., Proc., 
17: 323 ( 1958) • 
74. Turner, C. D. General Endocrinology. Philadelphia W. B. 
Saunders Company , 1960 . 
7~. Umbreit, W.W., R.H. Burris, and J. F. Stauffer. Manometric 
Techniques. Minneapoli s: Burgess Publishing Company, 1957. 
76. Villee, C. A., V. K. White, and A. B. Hastings . Metabolism of c14-
labeled Glucose and Pyruvate by Rat Diaphragm Muscl e in 
Vitro, J. Biol . Chem., 195:287 (1952). 
77. Weber, G., C. Allard, C. deLamirande, and A. Cantero. Liver 
Glucose-6 -Phosphatase Activity and Intracellular Distri-
bu tion After Cortisone Administration, Endocrino l ., 58:40 
( 1956 ). 
48 
78. Weber, G., C. Allard, G. detamirande, and A. Cantero. Increased 
Liver Glucose-6-Phosphatase Activity After Cortisone Ad-
ministration, Biochem. Biophys. Acta, 16:613 (1950). 
79. Welt, I. D., D. Stetten, D. J. Ingle, and E. H. Morley. Effect 
of Cortisone Upon Rates of Glucose Production and Oxidation 
in the Rat, J. Biol. Chem., 197:57 (1952). 
80. West, K. M. Comparison of the Hyperglycenic Effects of 
Glucocorticoids in Human Beings, Diabetes, 6: 168 ( 1957). 
81. Willmer, J. s. Changes in Hepatic Enzyme Levels After 
Adrenalectomy. I. Phosphorylase, Phosphoglucomutase·, and 
Phosphoglucose Isomerase, Canad. J. Biochem., 38:1005 
(1961). 
82. Winternitz, w. W. and w. G. Forrest. Metabolism of 2-c14-Pyruvate 
. After Adrenalectomy, Am. J. Physiol., 199:1054 (1960). 
83. Winternitz, W. ~. and D. t. Kline. Respiratory Studies on 
the Utilization of Carbohydrates After Adrenalectomy, 
Am. J. Physiol., 192:506 (1958). 
84. Winternitz, W. w., R. Pintzis, and C. N. H. I.ong. Further 
Studies on the Adrenal Cortex and Carbohydrate Metabolism, 
. Endocrinol., 61:724 (1957). 
APPENDIX 
49 
5U 
EXPERIMENT I 
OXYGEN UPTAKE (rL/MG. LIVER) AT 10, 20,AND 30 MINUTES OF INCUBATION BY 
RAT LIVER HOMOGENATES. TREATMENTS ADMINISTERED I.M. 5 HOURS BEFORE 
SACRIFICE. GROUP 1: 1.0 ML. PSS; GROUP 2: 0.5 MG. PREDNISOLONE; 
GROUP 3: 5.0 MG. PREDNISOLONE; GROUP 4: 20.0 MG. PREDNISOLONE 
Group 1 Group 2 
Incubation Time (Minutes) Incubation Time (Minutes5 
10 20 30 10 20 30 
13.5 25.0 38.3 16.0 27.0 34.7 
14.1 25.9 38.1 15.6 24.0 37.4 
10.9 23.1 25.1 12.7 24.4 26.9 
7.8 10.2 12.4 12.5 20.2 24.2 
ll.4 12.8 21.5 13.7 24.4 31.2 
13.7 29.8 36.5 16.6 29.6 39.7 
16.4 31.3 44.9 16.9 29.4 37.0 
14.0 25.3 30.5 14.4 27.l 35.6 
15.0 27.2 34.9, 13.9 24.5 29.2 
13.l 25.l 30.0 14.l 26.9 36.6 
Mean: 
130'0 24.1 31.2 14.6 25.8 33.3 
S.D. 
2.4 6.1 9.5 1.6 2.8 3.9 
Group 3 Group 4 
·-····~---~------~--~-----~--
18.7 35.6 43.8 19.2 37.4 41.2 
18.8 38.3 54.4 20.4 38.3 53.9 
11. 7 21.0 23.3 15.0 28.6 37.0 
16.6 29.7 41.9 12.5 24.4 33.8 
18~4 32.7 39.8 17.l 32.8 44.7 
15.l 28.2 35.7 15.5 31.2 43.5 
17.3 32.4 43.0 14.8 28.2 37.6 
16.0 30.8 40. 7 14.3 27.4 37.3 
12.6 23.5 28~8 16.8 32.8 44.5 
14.2 29.0 40.2 · 15. l 29.4 38.2 
Mean: 
15.9 30.1 39.2 16 .1 31.l 41.2 
S.D • 
., 
2.5 5.2 7.3 2.4 4.4 5.8 
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EXPERIMENT I I 
OXYGEN UPTAKE (µL/MG. LIVER) AT 10, 20, AND 30 MINUTES OF INCUBATION 
BY RAT LIVER HOMOGENATES. 5.0 MG. PREDNISOLONE ADMINISTERED I.M. 
AT DIFFERENT TIME INTERVALS BEFORE SACRIFICE. GROUP 1: 0.5 ML. 
PSS AT 8 HOURS; GROUP 2 AT 1 HOUR: GROUP 3 AT 2 HOURS; GROUP 
4 A'F>4 HOORS; GROUP 5 AT 8 HOURS 
Group 2 
Incubation 
Group 1 
Time (Minutes} Incubation Time (Minutes) 
10 20 30 10 20 
13.-7 19.8 20.4 16.7 27.7 32.9 
U.3 21.7 26. 7 12.0 - 22.8 31.8 
10.7 19.3 23.8 14.0 21.0 24.8 
11.5 20~'8 28.3 16.1 30.3 41.3 
7.8 11.9 14.5 13.4 22.9 29.1 
7.7 13.8 16.7 14.5 22.2 26.3 
15.l 26.7 30.7 10.5 20.6 24.4 
0.4 5.3 8.6 17.3 30.l 36.9 
11.1 17.6 22.5 8.5 10.9 13.1 
Mean: 
9.9 17.5 21.4 13.6 23.2 29.0 
s.o. 
4.1 6.0 6.7 2.8 5.6 7.7 
Group 3 Group 4 
18.3 31.7 43.1 17.2 29.7 41.1 
14.5 26.0 35.2 15.l 28.9 40.5 
16.3 29.0 40.1 15.2 26.4 35.8 
13.2 25.9 35.7 13.7 28d 38.4 
16.2 28.4 38.7 16.5 30.2 4L6 
15.l 25.5 37.3 
.-
14.2 25.9 37.0 
12.4 26.0 35.4 14.0 28.6 48.3 
16. 7 31.4 39.7 19.7 35.1 44.7 
12.3 19.5 23.1 17.2 31.5 38.3 
15.9 30.0 37.0 17.9 33.8 41.6 
Mean: 
15.l 27.3 36.4 16 .1 29.8 40.2 
s.o. 
1~9 4.9 5.3 1.9 2.9 2.8 
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EXPERIMENT II (Cont'd) 
Group 5 
Inc~bation Time (Minutes) 
19 20 30 
18.4 31.3 39.3 
14.b 27.2 37.5 
13.6 23.5 29.6 
14.b 26.0 35.1 
8.9 18.0 23.8 
17.5 33.l 41.9 
7.4 9.8 ll.8 
11.3 22.0 31.7 
14.3 25.6 30.0 
Mean: 
13.1 23.7 3U.9 
S.D. 
3.6 6.7 8.7 
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EXPERIMENT III 
OXYGEN UPTAKE- (pL/MG. LIVER) AT 10~ 20, AND 30 MINUTES OF INCUBATION BY 
RAT LIVER HCMOGENATES. TREATMENTS 'ADMINISTRATED 4 HOURS BEFORE SAC-
RIFICE. GROUP 1: INTACT, U.5 ML. PSS I.M.; GROJP 2: INTACT, 400 MG. 
GLUCOSE I.P.; GROUP 3: INTACT, 5.U MG. PREDNISOLONE I.M. 
(incubation Time) (Incubation Time) (Incubation Time) 
10 20 30 10 2U 30 10 20 30 
13.8 20.6 24.l 4.3 13:'2 14~5 2l.l 39.2 54.b 
12.6 19.S 22.2 12.1 19.7 23.5 13.9 20.6 25. 0 
15.9 29.6 36.7 13.4 22.5 27.6 13.7 19.4 23.b 
15.l 22.4 28.2 13 .3 · 18.2 21.2 14.6 28.0 37.6 
12.5 26. l 33.u 10.4 18.3 2u.9 12.9 25.3 32.3 
10.9 19.9 23.7 10.3 17.l 2U.9 15.9 32.1 45.8 
14.4 29.5 37.3 13.7 26.9 33.6 15.3 3U.9 37.4 
16.9 3U.l 36.o 15.7 26.l 3U.4 16.3 3U.U 43.U 
16.4 31.4 41.U 14.8 26.2 32.5 2U.4 39.6 '53. 1 
13.2 18.9 22.8 14.8 28.7 35.l 18.9 35.2 49.2 
13.1 25.2 36.5 12.8 22.5 29.4 13.1 27.4 37.U 
16.4 33.9 46.9 15.7 31.4 43.3 13.2 26.6 36.3 
11.9 25.5 30.7 16.1 30.2 36.9 16.0 29.4 39.8 
13.9 27.6 38.5 11.9 21.0 26.2 18.6 34.3 40.7 
17.9 31. 7 35.2 17.4 32.8 41.2 22.0 43.9 57.4 
Mean: 
14.3 26.l 32.9 13.4 23.7 27.8 15.4 30.8 40.9 
s.o. 
2.03 4.9 7.4 2.3 5.8 10.9 5.3 6.9 10.0 
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EXPERIMENT I I I 
OXYGEN UPTAKE (µ 1./MG. LIVER) AT 10, 20, AND 30 MINUTES OF INCUBATION 
BY RAT LIVER HCMOGENATES. TREATMENTS ADMINISTERED 4 HOURS BEFORE 
SACRIFICE. GRCUP. 4: INTACT, 400 MG. GLUCOSE I.P. AND 5.0 MG. 
PREDNISOLONE I.M. ;ORCUP 5: ADRENALECTCMIZED, 0.5 ML. PSS I.M. 
GRCUP 6; ADRENAlECTCMIZED, 400 MG. GLUCOSE I.P. 
Group ' 4 
(Incubation Time) Group 5 (Incubation Time) Group 6 (Incubation Time) 
10 20 30 10 20 30 ro 20 30 
15.0 30.8 39.7 7.4 9.9 12.6 10.3 15.0 17.6 
19.0 36.8 51.0 13.7 20.0 22.8 12.2 20.5 24.8 
20.7 36.0 44.2 16.5 27.6 32.9 17.9 26.5 32.2 
16.7 31.1 36.7 16.1 24.4 30.0 10.1 14.9 19.2 
12.3 26.5 34.6 11.5 18.4 22.4 10.8 19.3 23.3 
17.6 30.7 35.7 9.6 16.2 19.2 13.5 25.8 31.1 
18.6 38.6 49.9 14.l 23.7 26.9 15.2 24.8 29.5 
19.2 35.5 49.7 7.7 19.2 24.8 14.0 19.0 22.8 
17.2 33.6 45.7 14.4 28.0 38.0 15.6 28.8 35.8 
17.6 32.7 47.0 18.0 31.3 43.1 15.3 28.6 38.7 
17.3 34.5 51.0 13.3 25.8 33.7 14.2 26.6 34.4 
12.7 26.4 37.5 12.1 23.9 30.2 12.1 19.9 23.2 
21.2 39.8 55.9 15.7 29.0 38.6 21.3 39.9 54.3 
21. 7 40.1 48.6 13.4 . 20.3 22.7 14.8 26.2 31. 7 
16.2 28.3 31.B 15.2 30.5 36.2 12.9 25.0 30.5 
Mean: 
17.5 33.4 43.9 13.2 23.2 28.9 14.0 24.l 29.9 
s.o. 
2.8 4.5 7.4 3.1 5.9 8.2 2.9 6.3 9.1 
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EXPERIMENT III 
OXYGEN UPTAKE (uL/MG. LIVER) AT 10, 20, AND 30 MINUTES OF UNCUBATION BY 
RAT LIVER HCMOGENATES. TREATMENTS ADMINISTERED 4 HCVRS BEFORE SAC-
RIFICE. GROUP 7: ADRENALECTCMIZED, 5 MG. PREDNISOLONE I.M.; GRCVP 
8: ADRENALECTCMIZED, 5 MG. PREDNISOLONE I.M. AND 400 MG. GLUCOSE 
I.P.; GRCVP 9: FASTED-ADRENALECTCMIZED, 0.5 ML. PSS I.M. 
Group 7 Group 8 Group 9 (Incubation Time) (Incubation Time) (Incubation Time) 
10 20 30 10 20 30 10 20 30 
15.1 27.6 33.7 12.5 24.7 31.6 10.5 16.0 22.3 
18.4 36.0 48.4 19.7 36.1 49.6 4.0 10.1 16.3 
23.7 40.7 54.8 24.7 38.4 49.8 5.0 12.9 18.4 
13.6 20.7 24.0 14.1 27.8 37.7 7.7 12.0 15.1 
17.0 27.4 32.8 10.9 16.0 19.7 18.4 25.7 30.7 
18.6 32{4 37.9 16.1 29.0 35.9 12.6 16.2 21.2 
14.9 22.4 26.6 14.4 22.2 26.1 7.8 12.1 15.6 
-18 .1 31.5 38.8 19.1 31.8 37.3 10.2 15.8 18.9 
14.8 27.2 35.7 18.5 32.3 38.1 14.2 22.,5 26.1 
16 .1 29.0 39.0 17.2 30.5 42.0 9.6 16.5 19~2 
15.6 31.8 45.0 14.9 27.6 33.0 
18.4 34.6 45.4 15.8 31.3 42.0 
19.2 36.4 50.5 25.1 47.0 65.2 
18.2 36.0 46.4 19.2 33.5 41.5 
22.6 37.6 44.1 15.1 21.0 23.6 
Mean: 
17.6 31.4 40.1 16.8 29.9 38.2 10.0 16.0 21.4 
S.D. 
2.8 5.7 8.7 4.4 7.5 11.4 4.3 4.9 5.0 
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EXPERIMENT II I 
OXYGEN UPTAKE (uL/MG. LIVER) AT 10, 20 AND 30 MU'lJTES INCUBATION BY RAT'' 
LIVER HCMOGENATES. TREATMENTS ADMINISTERED 4 HCURS BEFORE SACRIFICE. 
GRCUP 10: FASTED-ADRENALECTOMIZED, 400 MG. GLUCOSE I. P.; .GROUP 11: 
FASTED-ADRENALECTCMIZED, 5 MG. PREDNISOLONE I.M.; GRCUP 12: 
FASTED-ADRENALECTCMIZED, 5 MG. PREDNISOLONE I.M., 400 MG. 
GLUCOSE I • P. 
Group 10 Group 11 Group 12 
(Incubation Time) (Incubation Time) (Incubation Time) 
10 20 30 10 20 30 10 20 30 
6.7 13.4 17.0 28.8 58.3 82.9 9.6 15.3 17.4 
4.6 14.3 21.1 12.0 20.8 25.7 15.6 23.4 25.3 
3.0 9.3 11.3 3.7 7.8 11.1 32.4 51.9 59.2 
10.4 15.3 19.8 13.0 25.4 30.1 16.4 27.1 30.5 
5.1 8.7 12.3 20.1 39.6 47.1 8.0 13.8 16.3 
6.7 13.4 17.2 15.8 27.6 35.5 16.8 32.9 39.7 
5.2 7.8 9.9 20.9 33.7 37.9 15.9 22.5 26.0 
7.1 13.3 16.7 18.8 36.2 45.3 12.0 22.4 28.1 
9.5 16.5 19.9 5.7 8.7 9.7 17.0 27.7 32.5 
12.0 16.9 18.9 20.8 30.2 35.9 26.3 43.5 49.8 
Mean: 
7.0 12.9 16.4 16.0 28.8 36.1 .1 17.0 28.1 32.5 
S.D. 
2.8 3.2 3.9 7.6 18.2 20.7 7.3 11.9 13.4 
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EXPERIMENT III - GROUP I 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCOGEN, AND TOTAL CARBOHY-
DRATE (EACH EXPRESSED AS GM.% OF GLUCCSE) BEFORE AND AFTER 30 MINUTES 
INCUBATION UNDER OXYGEN. INTACT CONTROL RATS RECEIVED 0.5 ML. PSS 
I.M. 4 HOURS BEFORE SACRIFICE 
RGI* Glyco~en Total Carbohydrate i 
Be- After Differ- Be- After Differ- Be- After Difter-
fore ence fore ence fore ence 
3.32 6.08 2.76 6.64 1.11 5.53 9.96 7.19 2.77 
3.24 5.43 2.19 6.27 12.53 -6.26 9.51 12.96 -3.45 
1.44 4.87 3.43 6.52 10.06 -3.54 7.96 14.93 -6.97 
2.07 2.67 0.60 0.75 0.19 0.56 2.75 2.86 ..:0.11 
2.37 4.32 1.95 15.86 3.02 12.84 18.23 7.34 10.89 
2.72 4.76 2.04 12.53 8.52 4.01 15.25 13.28 1.97 
1.98 4.25 2.27 6 .23 2.15 4.08 8.21 6.40 1.81 
2.79 4.97 2.18 9.34 9.22 0 .• 12 12.13 14.19 -2.06 
1.19 4-;22 3.03 8.07 21.09 -13.02 9.26 25.31 -16.05 
1. 72 4.30 2.58 9.35 5.69 3.66 11.07 9.99 1.08 
1.31 4.07 2.76 27.31 12.63 14.68 28.62 16.70 11.92 
1.48 4.15 2.67 25.07 18.66 6.41 26.55 22.81 3.74 
1.07 3.55 2.48 4.91 3.86 1.05 5.98 7.41 -1.43 
1.14 3.44 2 .30 0.54 1.40 -0 .• 86 1.68 4.84 -3.16 
2.20 5.49 3.29 8.46 2.63 5.83 10.66 8.12 2.54 
Mean: . 
2.00 4.44 2.44 9.86 7.52 2.34 11.85 11.62 0.23 
S.D. 
0.75 0.87 0 . 67 7.68 6.52 o . 93 7.64 6 . 44 6 . 71 
*Reducing Glycolytic Intermediates 
EXPERIMENT III - GROUP 2 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES , GLYCCGEN, AND TOTAL CARBOHY-
DRATE (EACH EXPRESSED AS GM .% OF GLUCOSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. INTACT RATS RECEIVED 400 MG.GLUCOSE 
I . P. 4 HaJRS BEFORE SACRIFICE 
RGI* Gl:tco~en Total Carbohydrate 
Be- After Differ- Be- After Di ff er- Be- After Di ff er'-
fore ence fore ence fore ence 
2 . 97 5 . 34 2 . 37 3.96 2 . 28 1.68 6.93 7 . 62 -0.69 
3 . 76 4 . 95 1.19 3.54 4.76 -1.22 7.30 9.71 -2 . 41 
1. 79 5.37 3.58 6.09 6.27 -0 . 18 7.88 11 . 64 -3.76 
1.88 1. 71 -0.17 2·.73 Oi.34 2.39 4.61 2.05 2 . 56 
2 . 12 · . 3. 78 1.64 6 . 52 2.99 3.53 8.64 6.75 1.89 
2 .85 3 . 93 1.08 6 . 02 3.59 2.43 8 . 87 7 . 52 1.3() 
2.08 4 . 61 2 .53 5 . 04 3 . 76 1.28 7.12 8.37 -1.25 
2.92 '5 . 60 2.68, 5.01 2.13 1.88 7 . 63 8 . 73 -0 .80 
1.68 3 . 96 2.28 4 . 65 2.57 2.08 6 . 33 6.53 -0.20 
1.65 4.05 2 . 40 10.03 5 . 74 4 . 29 11 .68 9.79 · 1.89 
1.59 1.63 0·.04 . 18 . 55 14.67 3.88 20 . 14 16.30 3.84 
1.68 5 . 61 3 . 93 22.88 0.75 22.13 2~.56 6 . 36 18.20 
1.00 3 . 78 2 . 78 4.57 9.45 -4.88 5.57 13 . 23 -7.66 
1 . 00 2 .93 1.93 1.64 L64 o.o 2 . 64 4.57 -1.93 
2.15 5 . 37 3 . 22 6 ~27 0.45 5 . 82 8.42 5.82 2.60 
Mean : 
2.07 4.17 2 . 10 1.17 4 . 16 3.01 9.24 8.33 0.91 
S.D. 
0.76 1.30 1.18 5.88 3.79 5.87 5.76 3.52 5.69 
*Reducing Glycolytic Intermediates 
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EXPERIMENT III - GROUP 3 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCOGEN, AND TOTAL CARBOHY-
DRATE (EACH EXPRESSED AS CM.% OF GLUCOSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. INTACT RATS RE(::EIVED .= 5.0 MG. 
PREDNfSOLONE ' I :M. 4 HOORS BEFORE SACRIFICE 
RGI* Glycogen Total Carbohydrate 
Be- After Differ- Be- After Differ- Be- After Differ-
fore ence fore ence fore ence 
4.40 6.51 2.11 7.06 12.65 -5.59 11.46 19.16 -7.70 
0.54 7.52 6.98 9.49 9.84 -0.36 10.03 17.37 -7.34 
2.12 4.43 2.31 7.10 1.39 5.71 9.22 5.82 3.40 
1.86 4.30 2.44 10.03 4.48 5.55 11.89 8.88 3.01 
2.96 5.35 2.39 5.43 4.43 l'.' 00 8.39 9.78 -1.39 
1.87 3.88 2~01' 7.22 3.25 3.97 9.09 7.13 1.96 
2.77 5.11 2.34 16.82 9.30 .7.62 10.59 14.41 5.18 
1.29 4.75 3.46 21. 78 5.46 16.32 23.07 10.21 12.86 
2.33 5.34 3.01 9.58 6.45 3.13 11.91 11.79 0.12 
2.16 4.86 2.70 22.74 14.40 8.34 24.90 19.26 5.64 
1.54 4.86 2.70 22.82 13.12 9.70 24.36 17.51 6.85 
1.46 6.23 4.77 4.83 0.86 3.97 6.29 7.02 -0.08 
1.07 2.97 1.90 11.39 17.73 -6.34 12.46 20.70 -8.24 
1.39 4.40 3.01 1.65 2.84 -1.19 3.04 7.24 -4.20 
1.84 5.03 3.19 5.55 2.69 2.86 7.39 7.72 -0.33 
Mean: 
1.97 5.00 3.03 10.90 7.26 3.64 12.87 12.27 0.60 
S.D. 
0.92 1.11 1.30 6.90 5.26 6.32 6.84 5.27 6.04 
*Reducing Glycolytic Intermediates 
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EXPERIMENT III - GROUP 4 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCOGEN, AND TOTAL CARBOHY-
DRATE (EACH EXPRESSED AS G.M.% OF GLUCOSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. INTACT RATS RECEIVED 400 MG. 
GLUCOSE I.P. AND 5.0 MG. PREDNISOLONE I.M. 4 HClJRS BEFORE 
SACRIFICE 
RGI* Glycogen Total Carbohydrates 
Be- After Differ- Be- After Di ff er- Be- After Differ-
fore ence fore ence ·fore ence 
3.43 4.09 0.66 4.01 3.27 0.74 U.44 7.36 0.08 
2.11 6.47 4.36 12.48 8.72 3'i76 14.59 15.19 -0.6() 
2.23 4.83 2.60 9.98 5.37 4.57 12.17 10.20 1.97 
2.85 5.28 2.43 4.82 5.69 -0.87 7.67 10.97 -3.30 
2.70 4.82 2.12 14.56. 6.56 8.00 17.26 11.38 5~9s· 
2.07 4.68 2.61 10.44 4.18 6.26 12.51 8.86 3.65 
2.94 5.75 2.81 4.61 11.52 -6 .91 7.66 17.27 -9.72 
1.38 4.25 2.87 7.93 15.34 -7.41 9.31 10.59 -10.28 
2.21 4.49 2.26 8.89 3.12 5.77 11.10 7.61 3.49 
2.26 4.94 2.68 18.90 12.53 6.37 21.16 17.47 3.69 
2.04 4.91 2.87 14.29 14.20 0: 09 16.33 19.11 -2.78 
1.37 3.39 2.02 2.22 0.29 1.93 3.59 3.68 -0.09 
1.63 4.76 3.13 6.06 6.27 -0.21 7.69 11.03 -3.34 
1. 77 4.38 2.61 1.55 1.66 -0.11 3.32 6.04 -2.72 
Mean: 
2.29 4.78 2.49 8.94 7.04 1.90 11.23 11.81 -0.59 
s.o. 
0.65 0.71 0.83 5.09 4.56 4.69 5.23 4.90 4.91 
*Reducing Glycolytic Intermediates 
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EXPERIMENT III - GROUP 5 
-LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCcx;EN, AND TOTAL CARBOHY-
DRATE (EACH EXPRESSED AS CM% OF GLUCCSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. ADRENALECTCMIZED CONTROL RATS 
RECEIVED U'.:) Mt .. PSS . I ,:M . -~ BOORS BEFORE SACRiEFICE 
RGI* Gl:t:cogen Total Carbohydrate 
Be- After Differ- Be- After Di ff er- Be- After Differ-
fore ence fore ence fore ence 
', 
2.83 4.55 1. 72 4.37 0.26 ', 4 . 11 7.20 4.81 2.39 
3 . 61 4.79 1.18 1.69 1.88 -0.19 5.30 6.67 -1.37 
2.33 4.83 2.50 7.16 7.34 -0.18 9.49 12.17 -2.68 
1.98 4.71 2.73 12.86 7.26 5.24 rn.48 12.33 2.15 
2.35 4.23 1.88 9.70 5.05 4.6~ 12.05 9.28 2.77 
2.41 3.96 1.55 3.36 3.36 0.0 5.77 5.32 0.45 
1.96 4.79 2.83 7.24 2.73 4.51 9.20 7.52 1.68 
2 . 39 3.99 1.60 6 .72 7.63 -0.91 9.11 11.62 -2.51 
1.33 3.36 2.03 9.99 5.54 4.45 11.32 8.90 2.42 
2.15 3.82 1.67 17.76 12.53 5.23 19~81 16.35 3.56 
1.42 3.72 2.30 33.42 23.81 9.61 34.84 27.53 7.31 
1.43 3.12 1.69 4.05 0.96 0.09 5.48 4.08 1.40 
1.11 3.89 2.78 17.49 13.65 3.84 18.60 17.54 1.06 
1.11 _ 2.92 1.81 2.51 ... 2.6t -0.10 3.62 5.53 -1. 9-1 
1. 79 3.97 2.18 2.86 0.09 2.77 4.65 4.06 0.59 
Mean: 
2.01 4.04 2.03 9 .41 6.34 3.07 11.40 10. 25 1.15 
S .D. 
0.69 0 .61 0 . 60 8.37 6.35 2 .88 8.13 6.41 2 . 61 
* Reducing Glycolytic Intermediates. 
"· 
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EXPERIMENT III - GRCUP 6 
LIVER REDUCING LYCOLYTIC INTERMEDIATES, GLYCCGEN, AND TOTAL CARBOHY-
DRATE (EACH EXPRESSED AS~.% OF GLUCOSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. ADRENALECTCMIZED RATS RECEIVED 
400 MG. GLUCOSE I.P. 4 HOJRS BEFORE SACRIFICE 
RGI* 
-
Glycogen Total Carbohydrate 
Be- After Di ff er- Be- After Di ff er- Be- After Di ff er-
fore ence fore ence fore ence 
2.58 2.46 -0.12 3.42 0.34 3.08 6 .00 2.80 3.20 
2.76 7.02 4.26 10.86 11.45 -0.59 13.62 18.47 -4.85 
2.57 5.56 2.99 19.00 4.45 14.55 21.57 10.01 11.56 
2.34 4.05 1.99 7.62 4.49 3.13 9.96 8.54 1.42 
2.16 3.43 1.27 3.48 2.48 1.00 5.64 5.91 -0.27 
1.95 4.26 2.31 7.71 4.92 2.79 9.66 9 .18 0.48 
2.13 3.80 1.67 3.12 0.86 2.26 5.25 4:66 0.59 
1. 73 4.27 2.54' 3.65 0.33 3.32 5.38 4.60 0.78 
1.50 3.18 1.68 3.22 15.04 -11.82 4.72 18.22 -13.50 
1.46 1.67 0.21 20.37 17.96 2.41 21.83 19.63 2L20 
1.85 4.34 2.59 15.35 16.53 -1.18 17.20 20.87 -3.67 
1.50 2.90 1.40 2.10 1.05 1.05 3.60 3.95 -0.35 
0.95 4.66 3. 71 8.95 12.78 -3.83 9 .90 17.44 -7.54 
1.04 3.67 2.63 6.36 1.52 4.84 7.40 5.19 2 .21 
1.59 3.46 1.87 5.08 1.12 3.96 6.67 4.58 2.09 
Mean: 
1.87 3.92 2.05 8.02 6.35 1.66 9.89 10.27 -0.39 
S.D. 
0.55 1.27 1.15 5.92 6.47 5.45 6 .00 6.67 5.54 
* Reducing Glycolytic Intermediates 
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EXPERIMENT III - GRCXJP 7 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCOGEN, AND TOTAL CARBOHY -
ORATE (EACH EXPRESSED PS GM.% OF GLUCCSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. ADRENALECTCMIZED RATS RECEIVED 5.0 
:MG.., PREDNISOLONE Ii~M:; 4'. HCXJRS BEFORE SA~RIFICE 
RGI* Gl:;lcogen Total Carbohydrate 
Se- After Differ- Be- After Differ- Be- J\fter Differ-
fore ence fore ence fore ence 
3.22 '.h48 0.26 3.01 5.05 -2.04 6.23 8.53 -2.30 
3.76 7.95 4.19 ~.69 12.89 -7.20 9.45 20.84 -11.39 
2.43 6.17 3.74 14.93 11.06 3.87 17.36 17.23 0.13 
2.35 4.47 2.12 7.37 11.13 -3.76 9.72 15.60 -5.88 
2.43 4;~7 2.04 13.56 8.41 5.15 15.99 12.88 3.11 
2.58 9.34 6.76 ·ei.J.:5 1.48 a.in .8.J3 10.82 -2.09 
2.75 4.79 2.04 10.77 1~·.39 · -1.62 13.52 17 .18 -3.66 
1.60 3.81 2 .• 121 2.39 2.62 .. :o~.23 3.99 6.43 -2.44 
1. 76 3.05 1.29 9.24 5.91 3.33 11.00 8.96 2.04 
1.96 3.91 1.95 21.62 16.0 5.62 23.58 19.91 3.67 
1.33 4.13 2.80 20.63 15.90 4.73 21.96 20.03 1.96 
1.57 3.79 2.22 3.06 3.59 -0.53 4.63 7.38 -2.75 
1.05 3.92 2.87 12.J? · 6.93 5.44 13.42 10.85 2.57 
1.31 3.84 2.53 4.40 1.36 3.,04 5. 71 5.20 0.51 
1.67 3.88 2.21 3.64 0.49 3.15 5.31 4.37 0.9411 
Mean: 
2.12 4.73 2.61 9.26 7.69 1.57 11.37 12.41 -1.04 
S.D. 
0.76 3.08 1.46 6 .23 5.30 3.95 6.19 5.68 3.97 
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EXPERIMENT III - GROUP 8 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCOGEN, AND TOTAL CARBOHY-
ORATE (EACH EXPRESSED AS GM.% OF GLUCOSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. ADRENALECTaAIZED RATS RECEIVED 400 
MG. GLUCOSE I,P. AND 5.0 MG. PREDNISOLONE 
I.M. 4 HCURS BEFORE SACRIFICE 
' 
RGI* G!::£COgen Total Carbohi'.drate 
Be- ,After Differ- Be- After Differ- Be- After Di ff er-
fore ence fore ence fore ence 
3.45 4.11 0.66 4.98 8.94 3.96 8.43 ' 13.05 -4.62 
2.42 6.80 4.38 6.65 8.77 :;2:12 9.07 15.57 -6.50 
2.16 5.45 3.29 33.84 28.20 5.64 36.00 33.65 2.35 
2.22 4.76 2.54 8.19 3.76 4.43 10.41 8.52 1.89 
2.69 4.66 1.97 8.33 4.74 3.59 11.02 9.40 1.62 
1.59 4.08 2.49 18. 71 16.11 2.60 20.30 20.19 0.11 
2.36 4.73 2.37 l~.72 10.!f>3 4.ID9 17.08 l~.2&. 1.82 
1.63 4.33 2.70 5.64 5.37 0.27 7.27 9.70 -2.43 
2.05 3.28 1.23 8.42 4.8'd 3.61 10.47 8.09 2.38 
1. 74 3.86 2.12 18 .15 13.48 4.67 19.89 17.34 2.55 
2.00 4.17 2.17 7.31 12.57 -5.26 9.31 16.74 -7.43 
1.40 3.87 2.47 2.11 3.01 .. u::.~o 3.51 6.88 -3.37 
1.21 4.95 3.74 15.98 8.36 7.62 17.19 13.31 3.88 
1.17 3.93 2.76 2.45 5.42 -2.97 3.62 9.35 -5.73 
1.94 5.28 3.34 10.34 6.02 4.32 12.28 11.30 0.98 
Mean: 
2.00 4.55 2.55 11.05 9.34 1. 71 · 13' 06 . . ·:o~ 13.89 -0.83 
s.o. 
0.60 0.94 0.93 8.20 6.48 3.95 8.20 6.72 3.80 
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EXPERIMENT III - GROUP 9 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCcx:;EN, AND TOTAL CARBOHY-
DRATE (E~CH EXPRESSED AS CM.% OF GLUCCEE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. FASTED-ADRENALECTCMIZED CONTROL 
RATS RECEIVED 0.5 ML. PSS I.M. 4 HOURS PRIOR TO SACRIFICE 
RGI* Gl:z::cogen Total Carboh~drate 
Be - After Differ- Be- After Di ff er- Be- After Differ-
fore ence fore ence fore ence 
0.93 1.62 0.69 1. 74 1.16 0.58 2.67 2.78 -0.11 
1.17 1.62 0.45 1.50 0.56 0.94 2.67 2.18 0.49 
1.31 2.03 0.72 2.62 1.63 0.99 3.93 3.66 0.27 
0.66 1.26 0.60 1.50' 1.96 -0.46 2.16 3.26 -1.06 
0.96 1.50 0.54 0.90 0.60 0.30 1.8() 2.10 -0.24 
0.87 1.39 0.52 1.45 0.14 1.31 2.32 1.53 0.79 
0.58 0.64 0.06 1.53 2.51 -0.98 2.11 3.15 -1.04 
0.52 1.07 0.55 1.48 1.25 0.23 2.00 2.32 -0.32 
0.73 1.38 0.65 1.09 2.43 -1.34 1.82 3.81 -1.89 
0.42 1.34 0.92 2.72 3.97 -1.25 3.14 5.31 -2.17 
Mean,: 
0.82 1.39 0.57 1.65 1.62 0.03 2.47 3.01 -0.54 
S.D. 
0.29 0.37 0.22 0.58 1.15 0.97 0.66 1.09 0.94 
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EXPERIMENT III - GROUP 10 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCOGEN, AND TOTAL CARBOHY-
DRATE (EACH EXPRESSED AS GM.% OF GLUCOSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. FASTED-ADRENALECTOMIZED RATS RE-
CEIVED 400 MG. GLUCOSE I.P. 4 HCURS BEFORE SACRIFICE 
RGI* Glycogen Total Carb6hydrate 
Be- After Differ- Be- After Differ- Be- After Differ-
fore ence fore ence fore ence 
0.81 1.29 0.49 1. 75 1.21 0;54 2.57 2.5U o.u7 
1.67 3.12 1.45 3.76 2.95 0.81 5.43 6.07 -0.64 
0.57 1.41 0.84 1.05 0.45 0.60 1.62 1.86 -0.24 
0.69 2.29 1.60 1.80 1.31 0.49 2.49 3.60 -1.11 
1.05 1.54 0.49 1.14 1.14 o.o 2.19 2.68 -0.49 
0.79 1.03 0.24 1.58 2.18 -0.60 2.37 _ 3.21 .... 0.84 
0.71 1.83 1.12 1.06 2.35 -1.29 1. 77 4.18 -2.41 
0.66 0.66 o.o 1.06 2.35 -1.29 1. 72 3.01 -1.29 
0.75 0~60 -0.15 1.07 1.07 o.o 1.82 1.67 0.15 
1.13 1.80 0.67 3.09 1.61 1.48 4.22 3.41 0.81 
Mean: 
0.88 1.56 0.68 1. 74 1.66 0.08 2.62 3.22 -p.60 
S.D. 
0.32 0.76 0.56 0.93 0.76 1.09 1.24 1.26 2.82 
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EXPERIMENT III - GROUP 11 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCOGEN, AND TOTAL CARBOHY-
DRATE (EACH EXPRESSED AS GM.% OF GLUCC6.E)· BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. FASTED-ADRENALECTCMIZED RATS RE-
CEIVED 5. 0 MG. PREDNISOLONE I.M. 4 HOURS BEFORE 
SACRIFICE. 
RGI Glycogen Total Carbohydrate 
Be- After Differ- Be- After Differ- Be- After Di ff er-
fore ence fore ence fore ence 
1.91 3.76 1.85 6.45 2.28 4.17 8.36 6.04 2.32 
1.41 2.65 1.24 3.01 1.80 1.21 4.42 4.45 -0.03 
1.03 2.05 1.02 1~20 -?.56 -:I:.36 2.23 -4.61 ·-2'.;;38 
0.75 1.59 0.84 J..30 1.16 0.14 2.05 2.75 -0·.70 
1.09 1.75 0.66 4.36 1.70 2.66 5.45 3.45 2.00 
1.05 1.14 0.09 . 2.73 1.82 0.91 3.78 2.96 0.82 
0.86 1.40 0.54 1.61 1.48 0.13 2.47 2.88 -0.41 
0.82 1.44 0.62 2.32 1.55 0.77 3.14 2.99 0~15 
0.66 0.66 o.o 2.26 1.50 0.76 2.92 2.16 0.76 
1.03 2.04 1.01 6.11 2.04 .4.07 7.14 4.08 3.06 
Mean: 
1.06 1.85 0.79 3.14 1.79 1.35 4.20 3.74 0.56 
S.D. 
0.36 0.86 0.54 1.89 0.41 0.45 2.16 1.15 1.61 
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EXPERIMENT III - GROUP 12 
LIVER REDUCING GLYCOLYTIC INTERMEDIATES, GLYCOGEN, AND TOTAL. CARBOHY-
DRATE (EACH EXPRESSED AS GM.% OF GLUCOSE) BEFORE AND AFTER 30 MIN-
UTES INCUBATION UNDER OXYGEN. FASTED-ADRENALECTOMIZED RATS RE-
CEIVED:: 400 MG·. GLUCOSE· I. P~ AND: ~:/. 0 MG. PREDNISOLONE I.M. 
4 HOURS :i3t:FORE1 SACRIFICE 
B~I* Gl~~Qg'an Tgtal Qerbgb~dtet~ 
Be- After Differ- Be- After· Differ- Be- After Differ-
fore ence fore ence fore ence 
1.45 3.12 1.67 2.60 2.02 0.58 4.05 5 .• 14 · -1.09 
1.44 3.76 2.32 9.02 5.87 3115 10.46 9.63 0,.83 
1. 75 4.12 2.37 6.27 3.34 2.93 8.02 7.46 0.56 
0.75 2.52 1. 77 3.76 0.81 2.95 4.51 3.33 1.18 
0.82 1.70 0.88 0.82 0.98 -0.16 1.64 2.68 -1.04 
0.78 2.40 1.62 2.31 l.88 0.43 3.09 3.48 -0.39 
1.26 2.43 1.17 6.30 2.99 3.31 7.56 5.42 2.14 
1.02 1.26 0.24 3.03 3.03 o.o 4.05 4.29 -0.24 
0.92 2.01 1.59 5.26 3 .• 01 2.25 6.18 5.52 o:.66 
1.26 3.49 2.23 7.39 2.82 4.57 8.64. 6.31 2.33 
Mean: 
1.15 2.73 1.58 4.63 2.68 2.00 5.82 5.33 0.49 
S.D. 
0.34 0.89 1.18 2.58 1.43 .. :-l:-~65 2.80 2.10 1.19 
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